General symptoms and signs

R18_GENERAL_SYMPTOMS_SIGNS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R50-R69 Cause of death: ICD-10 — R50-R69 2 out of 7 registries used, show all original rules.	166251
4. Check minimum number of events None	166251
5. Include endpoints R18_FEVER_OTHER_UNKNO_ORIGIN R18_HEADACHE1 R18_PAIN_NOT_ELSEW_CLASSIFIED R18_MALAI_FATIG R18_SENILITY R18_SYNCO_COLLAP R18_CONVU_NOT_ELSEW_CLASSIFIED R18_SHOCK_NOT_ELSEW_CLASSIFIED R18_HAEMORRHAGE_NOT_ELSEW_CLASSIFIED R18_ENLARGED_LYMPH_NODES R18_OEDEMA_NOT_ELSEW_CLASSIFIED R18_HYPERHIDROSIS R18_LACK_EXPEC_NORMAL_PHYSIO_DEVELOPMENT R18_SYMPTOMS_SIGNS_CONCERNI_FOOD_FLUID_INTAKE R18_CACHEXIA R18_OTHER_GENERAL_SYMPTOMS_SIGNS R18_UNKNO_UNSPE_CAUSES_MORBIDI	168636
6. Filter based on genotype QC (FinnGen only)	150225

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R
Name in latin: Symptomata et signa generalia

NAME	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	R18_FEVER_OTHER_UNKNO_ORIGIN\|R18_HEADACHE1\|R18_PAIN_NOT_ELSEW_CLASSIFIED\|R18_MALAI_FATIG\|R18_SENILITY\|R18_SYNCO_COLLAP\|R18_CONVU_NOT_ELSEW_CLASSIFIED\|R18_SHOCK_NOT_ELSEW_CLASSIFIED\|R18_HAEMORRHAGE_NOT_ELSEW_CLASSIFIED\|R18_ENLARGED_LYMPH_NODES\|R18_OEDEMA_NOT_ELSEW_CLASSIFIED\|R18_HYPERHIDROSIS\|R18_LACK_EXPEC_NORMAL_PHYSIO_DEVELOPMENT\|R18_SYMPTOMS_SIGNS_CONCERNI_FOOD_FLUID_INTAKE\|R18_CACHEXIA\|R18_OTHER_GENERAL_SYMPTOMS_SIGNS\|R18_UNKNO_UNSPE_CAUSES_MORBIDI
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R[5-6]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R[5-6]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to General symptoms and signs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	150225	85989	64236
Unadjusted period prevalence (%)	30.07	30.53	29.45
Median age at first event (years)	57.02	52.61	62.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
72651: Matched controls
363785

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

323.3

2810

6044

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

323.0

6875

20609

M01AB05

ATC

diclofenac; systemic, rectal

1.4

323.0

41641

180075

L03AA02

ATC

filgrastim; parenteral

3.2

321.6

1614

2558

SPAT1310

SPAT

Counselling related to known health issue

1.4

320.7

18805

71231

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

318.2

4069

10300

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.3

317.7

1527

2351

H02AB09

ATC

hydrocortisone; systemic

3.4

317.4

1434

2115

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

315.8

4195

10771

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

315.7

3487

8332

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

315.4

7144

21789

H02AB07

ATC

prednisone; oral

1.7

314.4

7403

22822

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

313.9

5552

15726

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

313.3

15820

58196

N05BA12

ATC

alprazolam; oral

1.8

313.3

5492

15511

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.6

310.7

577

337

J02AC01

ATC

fluconazole; systemic

1.4

310.3

23584

93403

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

309.5

13169

46779

D11

ICPC

Diarrhoea

1.7

309.4

7750

24289

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

307.7

2160

4175

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

307.7

4602

8973

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

7.0

307.7

1583

1154

D01

ICPC

Abdominal pain/cramps general

1.8

307.7

8199

23953

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

307.7

8303

24804

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

307.7

8758

20323

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

307.7

11714

34579

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

307.7

19717

63232

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

307.7

1753

2791

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

307.7

3154

5092

SPAT1153

SPAT

Removal of sutures

1.5

307.7

17263

63596

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

307.7

12587

37247

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

8423

22552

JN4AD

NOMESCO Finland

Body CT examination

2.3

307.7

6984

15801

C03CA01

ATC

furosemide; systemic

2.1

307.7

18047

48920

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

307.7

2535

5098

J01CA04

ATC

amoxicillin; systemic

1.5

307.7

56354

253011

Z3226

NOMESCO Finland

Physiotherapist

1.8

307.7

10620

31871

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

14327

46070

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

307.7

10780

25210

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

307.7

36132

148990

N03AE01

ATC

clonazepam; systemic

3.0

307.7

3649

6341

G44.2

ICD-10 Finland

Tension-type headache

2.5

307.7

10357

22655

SPAT1255

SPAT

Intravenous administration of medicine

2.2

307.7

3717

8601

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

307.7

4912

12950

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

307.7

7163

21030

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

307.7

6171

11154

N06AX16

ATC

venlafaxine; oral

2.3

307.7

10549

25200

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

307.7

7188

18828

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.1

307.7

1869

3065

E86

ICD-10 Finland

Volume depletion

3.9

307.7

1320

1738

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

26.9

307.7

1742

332

M54.2

ICD-10 Finland

Cervicalgia

1.9

307.7

4903

13068

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

307.7

4327

10146

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

19906

69011

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

8.4

307.7

889

537

L01

ICPC

Neck symptom/complaint

1.6

307.7

10115

33109

XW000

NOMESCO Finland

Bone marrow biopsy

3.0

307.7

2225

3787

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

307.7

3445

7967

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

37171

144047

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

307.7

7989

15757

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

307.7

3801

8783

A46

ICD-10 Finland

Erysipelas

1.9

307.7

8709

23820

R63.4

ICD-10 Finland

Abnormal weight loss

4.7

307.7

2698

2942

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

8.3

307.7

873

530

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

307.7

7616

15721

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

307.7

6220

17286

XF404

NOMESCO Finland

Ambulatory ECG

2.2

307.7

4775

11061

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

307.7

17349

47155

WZC30

NOMESCO Finland

Teaching

1.8

307.7

9828

29427

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

307.7

6660

12330

N03AX11

ATC

topiramate; oral

4.0

307.7

1729

2219

R51.81

ICD-10 Finland

Facial pain NOS

8.5

307.7

2000

1212

N06AX11

ATC

mirtazapine; oral

2.0

307.7

24243

73703

S18

ICPC

Laceration/cut

1.6

307.7

29919

111199

H02AB06

ATC

prednisolone; systemic

1.9

307.7

32721

110134

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

120.8

307.7

1163

R56.8

ICD-10 Finland

Other and unspecified convulsions

225.7

307.7

6488

158

N06AA09

ATC

amitriptyline; systemic

2.4

307.7

5568

12023

N02AA05

ATC

oxycodone; systemic

2.5

307.7

11688

25482

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.8

307.7

2398

4329

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

307.7

9349

25600

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

307.7

5072

12980

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

307.7

35439

138798

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

307.7

18435

67692

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

307.7

24839

88172

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.1

307.7

2067

3422

ZXD05

NOMESCO Finland

Urgent procedure

1.7

307.7

19384

63937

79199

ICD-8 Finland

Headache

+∞

307.7

995

X58

ICD-10 Finland

Exposure to other specified factors

1.7

307.7

9603

30479

R55

ICD-10 Finland

Syncope and collapse

25.8

307.7

12607

2937

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

307.7

18903

52786

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

307.7

5428

14734

N05BA01

ATC

diazepam; systemic, rectal

2.3

307.7

8499

19655

R13

ICD-10 Finland

Dysphagia

2.2

307.7

3862

9221

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

307.7

10499

29907

R07.3

ICD-10 Finland

Other chest pain

2.1

307.7

6358

16080

L03

ICPC

Low back symptom/complaint

1.6

307.7

18840

66725

M54.5

ICD-10 Finland

Low back pain

1.7

307.7

25335

85756

AA1AD

NOMESCO Finland

CT of head and brain

3.4

307.7

22716

42803

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

307.7

3561

6973

ZX120

NOMESCO Finland

Intravenous

2.3

307.7

5649

12831

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

307.7

13614

37668

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

307.7

6673

16225

SPAT1240

SPAT

Therapeutic discussion

1.8

307.7

6948

19861

N03AF02

ATC

oxcarbazepine; oral

5.6

307.7

2583

2374

N06AB06

ATC

sertraline; oral

2.0

307.7

7631

20649

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

307.7

9901

27726

N03AX14

ATC

levetiracetam; systemic

5.9

307.7

2152

1883

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.2

307.7

6426

10669

R51

ICD-10 Finland

Headache

3.6

307.7

4754

6976

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.6

307.7

3669

7249

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

307.7

4718

11167

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

307.7

2939

5441

N17

ICPC

Vertigo/dizziness

1.8

307.7

7420

21107

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

16578

54885

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

307.7

8210

22977

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

307.7

2869

5860

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

307.7

7551

20688

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

307.7

5733

13063

SPAT1254

SPAT

Administration of medicine

2.0

307.7

9329

24696

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

307.7

12454

40607

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

307.7

7146

18871

B01AA03

ATC

warfarin; systemic

1.7

307.7

9365

28868

R52.1

ICD-10 Finland

Chronic intractable pain

28.6

307.7

763

135

J01MA14

ATC

moxifloxacin; systemic

2.1

307.7

5099

12872

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.1

307.7

1330

1102

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

307.7

4805

12549

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

307.7

2440

4379

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

49458

209419

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.9

307.7

6957

12923

WX892

NOMESCO Finland

Monitored bed care

2.4

307.7

4527

9745

N05AX08

ATC

risperidone; systemic

2.2

307.7

5085

11931

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

307.7

4760

8808

A08

ICPC

Swelling

2.3

307.7

2993

6622

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

307.7

27892

82990

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

307.7

20066

52683

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.3

307.7

2016

3108

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

307.7

8574

16954

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.4

307.7

3093

6690

A02BC01

ATC

omeprazole; systemic

1.7

307.7

16683

54632

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

307.7

15275

45343

B01AC04

ATC

clopidogrel; oral

1.7

307.7

7860

24304

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

307.7

15050

39611

A04

ICPC

Weakness/tiredness general

2.1

307.7

11068

29111

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

29397

103832

N03AF01

ATC

carbamazepine; oral, rectal

3.0

307.7

3030

5187

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

307.7

6016

14709

M01AE02

ATC

naproxen; oral, rectal

1.4

307.7

37068

152091

A06AD11

ATC

lactulose; oral

2.2

307.7

8701

21290

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

307.7

6034

14003

N05AA02

ATC

levomepromazine; systemic

2.8

307.7

2419

4393

L17

ICPC

Foot/toe symptom/complaint

1.6

307.7

19306

67887

N30.0

ICD-10 Finland

Acute cystitis

1.8

307.7

10660

32101

Z71.8

ICD-10 Finland

Other specified counselling

1.5

307.7

22900

83387

C07AB07

ATC

bisoprolol; oral

1.8

307.7

29771

101154

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

307.7

10450

33920

R06.0

ICD-10 Finland

Dyspnoea

2.1

307.7

18145

50715

N06AX26

ATC

vortioxetine; oral

2.0

307.7

5140

13645

N02BF01

ATC

gabapentin; oral

2.2

307.7

6821

16213

A02BC03

ATC

lansoprazole; oral

1.6

307.7

16560

56296

ZY010

NOMESCO Finland

Hospital outpatient

2.3

307.7

3379

7502

N03AX09

ATC

lamotrigine; oral

3.5

307.7

3890

5826

A04AA01

ATC

ondansetron; systemic, rectal

2.3

307.7

5044

11273

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

307.7

6757

16989

UKC02

NOMESCO Finland

Cystoscopy

1.8

307.7

8596

25330

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

307.7

5078

11421

M04AA01

ATC

allopurinol; systemic

1.8

307.7

6471

18953

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

307.7

3637

7899

G47.3

ICD-10 Finland

Sleep apnoea

1.6

307.7

13968

48050

R51.80

ICD-10 Finland

Headache

11.6

307.7

20640

12039

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

307.7

49105

214856

A29

ICPC

General symptom/complaint other

1.8

307.7

8048

23049

M79.1

ICD-10 Finland

Myalgia

1.8

307.7

9648

28754

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

307.7

24211

93100

I95.1

ICD-10 Finland

Orthostatic hypotension

3.5

307.7

1989

2887

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.1

307.7

4020

9815

B01AB05

ATC

enoxaparin; parenteral

1.7

307.7

18716

62269

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

307.7

11002

37065

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

307.7

2355

3743

N02BE01

ATC

paracetamol; systemic, rectal

2.3

307.7

63270

271188

R60.0

ICD-10 Finland

Localized oedema

4.4

307.7

10245

13133

A28

ICPC

Limited function/disability NOS

2.2

307.7

10050

24560

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

307.7

25291

100244

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

307.7

6017

15284

N06AB10

ATC

escitalopram; oral

1.8

307.7

14424

44291

P01AB01

ATC

metronidazole; oral, rectal

1.6

307.7

25622

92943

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

307.7

35653

144766

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

307.7

3881

8424

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

307.7

16574

57698

A01

ICPC

Pain general/multiple sites

2.4

307.7

6671

14993

SPAT1263

SPAT

Sampling

1.6

307.7

27078

99110

Z2445

NOMESCO Finland

Psychologist

2.5

307.7

2534

5100

WW500

NOMESCO Finland

Blood transfusion

2.8

307.7

2250

4111

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

307.7

4387

10858

J01MA12

ATC

levofloxacin; systemic

2.1

307.7

11617

30343

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

307.7

4802

10083

TAB00

NOMESCO Finland

Lumbar puncture

3.5

307.7

3152

4669

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

307.7

14772

40525

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

307.7

16787

51293

N02BF02

ATC

pregabalin; oral

2.6

307.7

4574

9177

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

11.3

307.7

798

358

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

307.7

15493

51313

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

307.7

4472

8784

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

+∞

307.7

795

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.4

307.7

4025

4759

C08CA01

ATC

amlodipine; oral

1.5

307.7

20891

77761

R50.9

ICD-10 Finland

Fever, unspecified

11.9

307.7

18652

10300

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

307.7

4981

12046

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

28829

102948

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

307.7

8723

26018

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

307.7

12044

36049

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

307.7

1844

3039

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

11.6

307.7

3069

1373

N01

ICPC

Headache

2.1

307.7

8548

21391

Z2446

NOMESCO Finland

Social worker

2.5

307.7

4204

8632

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.7

307.7

742

489

N06AX12

ATC

bupropion; oral

1.9

307.7

4939

13275

J01AA02

ATC

doxycycline; systemic

1.5

307.7

50867

218675

S06.0

ICD-10 Finland

Concussion

2.3

307.7

7515

17546

WX402

NOMESCO Finland

General anaesthesia

1.5

307.7

13670

48287

J01DB01

ATC

cefalexin; oral

1.9

307.7

58517

247404

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

307.7

14195

40176

N03AG01

ATC

valproic acid; systemic, rectal

3.7

307.7

4571

6500

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

307.7

5794

14041

N06AX21

ATC

duloxetine; oral

2.7

307.7

8951

17983

JN4BD

NOMESCO Finland

Extensive body CT

2.4

307.7

5826

12956

M03BX02

ATC

tizanidine; oral

1.5

307.7

40927

167415

R06AE07

ATC

cetirizine; oral

1.4

307.7

28467

111942

Z2221

NOMESCO Finland

Medical doctor

1.5

307.7

15953

58233

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

307.7

30263

120300

S97

ICPC

Chronic ulcer skin

2.4

307.7

3377

7346

R52.9

ICD-10 Finland

Pain, unspecified

3.1

307.7

8305

14377

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

48069

175361

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

307.7

3510

7745

ZXA00

NOMESCO Finland

Right side

1.5

307.7

13866

49284

H02AB02

ATC

dexamethasone; systemic

1.9

307.7

6309

17025

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

307.7

9878

24241

W19

ICD-10 Finland

Unspecified fall

1.9

307.7

5924

16461

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

307.7

10018

21103

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

307.7

11637

23098

SPAT1260

SPAT

Consultation of another employee

1.6

307.7

10198

32798

N05CF02

ATC

zolpidem; oral

1.6

307.7

10314

33230

R33

ICD-10 Finland

Retention of urine

2.1

307.7

4058

10189

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

307.7

12318

33634

SPAT1301

SPAT

No procedures

1.6

307.7

19237

66476

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

28162

102477

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

17188

54776

N06AB03

ATC

fluoxetine; oral

1.8

307.7

7258

20889

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

307.7

3341

7534

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

307.7

3713

7607

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

307.7

21237

74502

R52.2

ICD-10 Finland

Other chronic pain

7.4

307.7

3251

2277

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

307.7

12585

38778

J01FA06

ATC

roxithromycin; oral

1.5

307.7

23739

90928

XA800

NOMESCO Finland

Neuropsychological investigation

2.6

307.7

2684

5193

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

307.7

5944

13231

N05CF01

ATC

zopiclone; oral

1.8

307.7

20411

64327

M25.5

ICD-10 Finland

Pain in joint

1.5

307.7

21265

76840

R02

ICPC

Shortness of breath/dyspnoea

1.9

307.7

8442

23158

SPAT1216

SPAT

Assessment of functional ability

1.9

307.7

8072

22871

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

307.7

4698

9204

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

11741

35721

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

26114

90578

P29

ICPC

Psychological sympt/compl other

1.9

307.7

5309

14291

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.3

307.7

2436

3731

J01FF01

ATC

clindamycin; systemic

1.7

307.7

17325

56020

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

307.7

10045

26830

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

307.7

3942

9256

P03

ICPC

Feeling depressed

1.8

307.7

7030

20821

N05CD07

ATC

temazepam; oral

1.8

307.7

5968

16996

L28

ICPC

Limited function/disability (L)

2.1

307.7

11450

29336

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.3

307.7

2469

3781

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

29927

94040

ZXE00

NOMESCO Finland

One hour or less

1.5

307.7

23753

88137

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

307.7

3800

8642

J01EA01

ATC

trimethoprim; systemic

1.5

307.7

14757

52429

N05AX12

ATC

aripiprazole; systemic

2.5

307.7

2845

5861

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

15996

40409

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

307.7

2933

6386

R53

ICD-10 Finland

Malaise and fatigue

4.2

307.7

24109

38165

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

307.7

22010

81979

E0000UV, ,

ATC

1.4

307.7

26595

104536

A02BA02

ATC

ranitidine; systemic

1.7

307.7

10293

32605

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

24817

84209

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.7

20328

63487

K02.1

ICD-10 Finland

Caries of dentine

1.4

307.7

39778

169678

H02AB04

ATC

methylprednisolone; systemic

1.7

307.7

8114

25188

N05BA04

ATC

oxazepam; oral

2.0

307.7

18226

52049

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

307.7

7927

12449

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

30305

104937

Z51.5

ICD-10 Finland

Palliative care

2.3

307.7

4406

10120

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

307.7

11541

37039

N05AH03

ATC

olanzapine; systemic

2.6

307.7

4501

9011

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

7.0

307.7

1660

1213

R05

ICPC

Cough

1.5

307.7

15440

55677

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

307.7

5861

14047

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

307.7

21316

80023

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.7

307.7

1215

1086

C07AA05

ATC

propranolol; systemic

1.8

307.7

13223

40666

WX002

NOMESCO Finland

Sedation and analgesia

1.7

307.7

10481

33276

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

307.7

34460

142636

M79.7

ICD-10 Finland

Fibromyalgia

3.0

307.7

2232

3801

C03DA01

ATC

spironolactone; oral

1.8

307.7

6477

18631

UJF32

NOMESCO Finland

Coloscopy

1.9

307.7

16185

48173

R11

ICD-10 Finland

Nausea and vomiting

2.8

307.7

6370

12159

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

307.7

11336

38014

N03AX12

ATC

[U] gabapentin; oral

2.6

307.7

11197

24077

R4110

NOMESCO Finland

Physiotherapy

1.7

307.7

17081

55876

K30

ICD-10 Finland

Functional dyspepsia

1.8

307.7

6846

20210

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

307.7

6042

17237

P01

ICPC

Feeling anxious/nervous/tense

1.7

307.7

9159

28835

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.3

307.7

2605

2129

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

307.7

9505

25693

A03

ICPC

Fever

1.7

307.7

12132

38237

R60.9

ICD-10 Finland

Oedema, unspecified

4.2

307.7

4156

5219

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

307.7

6332

17021

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

307.7

8028

22294

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

307.7

3292

6591

N06AB04

ATC

citalopram; systemic

1.9

307.7

13366

38779

A41.9

ICD-10 Finland

Sepsis, unspecified

3.2

307.7

1985

3200

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.2

307.7

2956

4756

R52.0

ICD-10 Finland

Acute pain

5.5

307.7

2730

2580

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

307.7

8283

19445

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

307.7

16083

50955

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

307.7

35008

96163

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

307.7

3490

7668

N03AX16

ATC

[U] pregabalin

2.5

307.7

16176

37898

N05AH04

ATC

quetiapine; oral

2.3

307.7

13568

32927

J01DA01

ATC

[U] cefalexin

1.5

307.7

39782

165494

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

307.7

9779

22472

SPAT1229

SPAT

Assessment of need for aid

2.4

307.7

3928

8630

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

306.1

10075

33801

A11

ICPC

Chest pain NOS

1.9

305.7

4684

12649

D06

ICPC

Abdominal pain localized other

1.8

305.6

5594

16011

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

303.1

1309

1869

127

Kela drug reimbursment

Transplant complication

4.4

302.4

1003

1158

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

302.3

3149

7341

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

302.3

3107

7202

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

301.7

3896

9893

SPAT1234

SPAT

Support of social functional capacity

2.4

301.5

2581

5511

J01FA10

ATC

azithromycin; systemic

1.4

301.2

37448

160181

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

300.7

5720

16564

R03DC03

ATC

montelukast; oral

1.6

299.9

9816

32874

ZXA05

NOMESCO Finland

Left side

1.5

299.8

12830

45589

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

14.3

299.4

429

151

G43.3

ICD-10 Finland

Complicated migraine

3.8

298.4

1187

1593

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

295.8

3733

9396

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

7.4

295.7

611

418

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.6

294.2

2127

4175

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

293.6

2248

4544

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

293.5

3763

9527

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

292.2

1461

2309

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

292.1

7123

22142

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

291.8

12958

46364

C07AB02

ATC

metoprolol; systemic

1.6

291.7

10031

33959

N07BB01

ATC

disulfiram; oral

2.3

290.8

2626

5747

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

290.3

2920

6704

Z00.0

ICD-10 Finland

General medical examination

1.5

290.0

11454

39982

XF402

NOMESCO Finland

ECG with work load test

1.8

289.9

5152

14599

183

Kela drug reimbursment

Lamotrigin and topiramate

6.8

288.0

635

474

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

287.5

3457

8538

M48.0

ICD-10 Finland

Spinal stenosis

1.7

286.1

5998

17867

A10AB05

ATC

insulin aspart; parenteral

1.9

285.8

4278

11451

L04AA06

ATC

mycophenolic acid; systemic

3.6

285.1

1196

1671

R4120

NOMESCO Finland

Occupational therapy

2.0

284.9

3667

9295

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

8.1

284.7

553

346

P06

ICPC

Sleep disturbance

1.6

284.2

8146

26391

R00.2

ICD-10 Finland

Palpitations

1.9

282.7

4769

13286

R5110, ,

SPAT

1.9

282.5

4423

12021

SFA10

NOMESCO Finland

One-surface restoration

1.3

281.7

36021

154042

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

281.0

2687

6032

P76

ICPC

Depressive disorder

1.9

280.7

4423

12046

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

279.6

2573

5678

R4190

NOMESCO Finland

Nutritional therapy

2.4

279.5

2427

5214

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

279.1

3279

8023

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

279.1

10618

36731

SPAT1262

SPAT

Handing over of treatment supplies

1.6

278.5

9021

30091

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

277.5

3219

7836

WX290

NOMESCO Finland

Other blockage of nerve

1.3

277.3

31653

132966

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

277.1

3088

7397

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

276.6

1791

3311

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

276.3

1949

3775

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

275.7

2208

4563

EBA00

NOMESCO Finland

Extraction of tooth

1.4

275.5

23144

92703

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

275.4

4400

12036

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

274.3

9287

31288

L12

ICPC

Hand/finger symptom/complaint

1.5

273.9

10470

36242

N03AX18

ATC

lacosamide; systemic

7.5

273.7

560

378

R41.0

ICD-10 Finland

Disorientation, unspecified

3.0

272.6

1529

2599

E87.6

ICD-10 Finland

Hypokalaemia

2.7

272.2

1817

3416

C01DA14

ATC

isosorbide mononitrate; oral

1.6

271.8

7069

22325

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.4

271.1

2264

4774

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

270.2

5309

15503

R05

ICD-10 Finland

Cough

1.5

270.1

12559

45263

M01AH05

ATC

etoricoxib; oral

1.3

269.9

39153

170088

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

269.0

7097

22493

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

268.4

15784

59462

R56.0

ICD-10 Finland

Febrile convulsions

446.3

268.2

355

S29

ICPC

Skin symptom/complaint other

1.5

268.1

11982

42832

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

267.6

7714

25001

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.6

267.4

1958

3867

C09AA05

ATC

ramipril; oral

1.5

266.4

12325

44360

R01AD09

ATC

mometasone; nasal

1.3

266.3

28508

118360

H03AA01

ATC

levothyroxine sodium; systemic

1.5

265.3

12681

45930

A04AA02

ATC

granisetron; systemic, transdermal

2.1

263.7

3233

8040

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

263.6

5459

16185

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.5

263.0

2107

4354

R03BB04

ATC

tiotropium bromide; inhalant

1.8

262.3

5037

14602

K59.0

ICD-10 Finland

Constipation

2.1

261.3

3106

7631

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

260.1

1316

2095

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

260.1

1730

3245

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

259.8

23309

94110

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

259.6

16670

63719

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

258.9

4465

12515

SPAT1097

SPAT

Recording of ECG

1.6

258.4

7126

22827

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.3

257.6

1225

1871

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

257.5

5091

14884

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

257.3

1025

1377

R74

ICPC

Upper respiratory infection acute

1.4

256.7

22014

88216

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

256.1

5615

16915

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

255.5

6760

21424

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

254.1

3916

10575

SPAT1312

SPAT

General health counselling

1.4

253.3

18967

74338

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

252.8

4274

11900

D07AC01

ATC

betamethasone; topical

1.4

251.7

21601

86504

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.3

251.7

851

999

R61.0

ICD-10 Finland

Localized hyperhidrosis

11.8

251.5

393

168

P15

ICPC

Chronic alcohol abuse

2.6

251.5

1873

3730

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.4

251.1

1168

1757

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.5

250.0

2007

4150

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

249.8

1881

3767

D09

ICPC

Nausea

2.1

249.3

2986

7355

U02

ICPC

Urinary frequency/urgency

1.6

249.1

8236

27545

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.2

248.7

522

365

J01FA09

ATC

clarithromycin; systemic

1.4

248.4

18334

71642

C09CA06

ATC

candesartan; oral

1.4

248.1

13676

50804

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

247.7

11096

39610

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

246.5

14395

54027

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

246.2

1981

4101

M03BX01

ATC

baclofen; systemic

3.5

245.8

1089

1583

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

245.2

4064

11240

PA6AD

NOMESCO Finland

CT of neck arteries

2.4

243.6

1986

4137

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.5

243.6

1877

3803

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

243.1

3130

7924

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

242.8

2120

4563

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

241.9

3036

7612

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

241.9

4433

12656

N05AF03

ATC

chlorprothixene; systemic

2.8

241.8

1516

2751

S22.3

ICD-10 Finland

Fracture of rib

1.9

241.4

3927

10792

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

241.4

2956

7342

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

241.1

4614

13348

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

240.8

4302

12184

P20

ICPC

Memory disturbance

1.7

240.8

6057

18928

TK800

NOMESCO Finland

Hemodialysis

3.3

240.8

1154

1772

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

240.7

1003

1394

G40

ICD-10 Finland

Epilepsy

6.0

240.6

582

487

N89

ICPC

Migraine

2.2

240.5

2403

5494

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

239.9

2009

4239

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

239.0

3650

9820

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

238.8

1221

1957

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

238.8

6764

21787

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.5

238.5

1055

1532

S01.0

ICD-10 Finland

Open wound of scalp

1.8

238.2

4243

12005

A99

ICPC

Disease/condition unspecnature/site

1.7

238.0

5858

18199

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.1

237.5

859

1068

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

237.1

14113

53093

JAH01

NOMESCO Finland

Laparoscopy

2.2

236.4

2563

6064

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.3

236.3

1115

1694

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.3

236.2

1156

1800

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

235.1

4396

12624

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

235.1

3675

9964

N06AX03

ATC

mianserin; oral

2.2

234.5

2446

5695

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

234.4

18107

71143

N88

ICPC

Epilepsy

8.4

234.1

442

265

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

234.0

7013

22894

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

233.5

2687

6512

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

233.4

7048

23049

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

233.3

44838

200558

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

233.2

3350

8822

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

232.8

23589

96567

AN1

Coronary angiography

1.7

232.0

4772

14098

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.8

231.7

1420

2543

R4110, ,

SPAT

1.6

231.5

7221

23796

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

231.4

4537

13215

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

231.4

6241

19847

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

231.4

2673

6488

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

231.1

5111

15415

B01AF02

ATC

apixaban; oral

1.6

230.8

6166

19561

U04

ICPC

Incontinence urine

2.1

230.6

2746

6745

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

230.0

1619

3130

XKD00

NOMESCO Finland

Uroflowmetry

1.6

229.8

7484

24910

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

229.8

3279

8614

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.4

229.6

2010

4330

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

229.1

2780

6878

N06AA10

ATC

nortriptyline; systemic

3.1

228.9

1177

1893

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

228.8

3382

8995

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

228.6

1053

1573

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

228.0

1323

2294

M01AH01

ATC

celecoxib; oral

1.5

227.9

9271

32396

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

227.3

1265

2139

L03AA13

ATC

pegfilgrastim; parenteral

2.2

226.8

2237

5084

J01CA08

ATC

pivmecillinam; oral

1.3

226.6

23084

94475

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.0

226.5

826

1034

R60.1

ICD-10 Finland

Generalized oedema

7.4

226.4

464

314

K07

ICPC

Swollen ankles/oedema

2.2

226.2

2240

5100

F10.24

ICD-10 Finland

Alcohol depence active use

3.6

225.6

946

1321

U07

ICPC

Urine symptom/complaint other

1.8

225.0

4547

13360

R03BA05

ATC

fluticasone; inhalant

1.5

224.8

10487

37659

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

223.6

4254

12275

K92.1

ICD-10 Finland

Melaena

2.1

223.4

2696

6655

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

223.3

6612

21508

R62.0

ICD-10 Finland

Delayed milestone

40.5

223.3

242

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

223.0

4379

12756

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

222.4

2066

4573

SFA20

NOMESCO Finland

Two-surface restoration

1.3

222.3

37824

165879

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

221.8

5210

15969

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

221.8

3208

8465

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

221.3

12301

45638

L29

ICPC

Musculoskeletal sympt/complt other

1.7

221.1

4957

15001

J05AB01

ATC

aciclovir; systemic

1.4

220.9

12321

45736

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.6

220.9

920

1278

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

220.9

6210

19942

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.1

220.6

1182

1952

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.1

220.5

1137

1832

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.3

220.1

1989

4347

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

220.1

6475

21025

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

219.7

1862

3950

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.7

219.5

881

1190

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

219.1

5755

18165

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

218.6

2265

5257

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.8

217.8

1345

2419

A07AA02

ATC

nystatin; oral

2.0

217.6

2851

7259

R96

ICPC

Asthma

1.7

217.4

5424

16891

SPAT1104

SPAT

Monitoring of emergency patient

1.9

216.9

3252

8687

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.8

216.9

1359

2464

R21

ICPC

Throat symptom/complaint

1.4

216.6

13930

52987

WX882

NOMESCO Finland

High dependency care

2.7

216.4

1495

2861

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

216.2

2704

6766

Z01.2

ICD-10 Finland

Dental examination

1.3

216.1

30050

128129

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

215.7

1782

3734

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

215.2

13317

50318

H01

ICPC

Ear pain/earache

1.5

214.7

7311

24557

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

214.5

3740

10500

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

214.3

12517

46815

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.1

214.1

605

600

F05.9

ICD-10 Finland

Delirium, unspecified

3.2

214.0

1054

1648

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

213.7

5353

16685

B01AB10

ATC

tinzaparin; parenteral

1.6

213.6

5750

18257

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

213.4

15762

61317

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

213.3

3481

9566

G50.1

ICD-10 Finland

Atypical facial pain

3.3

212.7

1016

1556

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

212.0

2401

5779

A41.8

ICD-10 Finland

Other specified sepsis

3.5

211.7

921

1321

L08

ICPC

Shoulder symptom/complaint

1.4

211.5

13036

49202

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

211.0

1371

2537

R01AD08

ATC

fluticasone; nasal

1.4

210.9

16838

66289

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

210.0

3038

8014

G04CA02

ATC

tamsulosin; oral

1.4

210.0

11416

42135

R35

ICD-10 Finland

Polyuria

1.9

209.3

3492

9665

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

209.2

2141

4942

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

209.2

1033

1618

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

208.6

1730

3632

D02

ICPC

Abdominal pain epigastric

1.8

207.5

3554

9919

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.3

207.3

970

1465

C10AA05

ATC

atorvastatin; oral

1.3

207.2

21936

89972

-1, ,

NOMESCO Finland

1.3

207.2

20469

83135

P74

ICPC

Anxiety disorder/anxiety state

2.0

206.8

2916

7622

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

206.7

3822

10925

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.2

206.6

1034

1634

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

205.9

2342

5646

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

205.7

12759

48175

R50.8

ICD-10 Finland

Other specified fever

7.7

205.2

409

266

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

205.2

3111

8339

M05BX04

ATC

denosumab; parenteral

2.0

205.2

2710

6918

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

205.0

2147

5004

D10

ICPC

Vomiting

1.8

204.8

3822

10956

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

204.7

3660

10353

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.8

204.7

817

1099

SPAT1211

SPAT

Application of soft bandage

1.7

204.6

4533

13660

L15

ICPC

Knee symptom/complaint

1.4

203.2

14392

55539

N05AN01

ATC

lithium; oral

2.7

202.8

1399

2675

N04BC05

ATC

pramipexole; oral

1.8

202.5

3635

10295

R03BA02

ATC

budesonide; inhalant

1.4

202.4

10136

36821

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

202.3

3910

11326

XQ800

NOMESCO Finland

Prick test

1.7

202.3

4174

12326

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.4

202.1

1769

3809

L02

ICPC

Back symptom/complaint

1.6

201.8

6147

20103

I50.0

ICD-10 Finland

Congestive heart failure

1.9

201.7

3264

8941

ZXA10

NOMESCO Finland

Bilateral

1.5

201.2

9349

33476

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

201.1

2129

4984

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

201.0

1663

3487

K08.3

ICD-10 Finland

Retained dental root

1.7

200.8

4164

12313

R31

ICD-10 Finland

Unspecified haematuria

1.7

200.6

5031

15674

A10AE04

ATC

insulin glargine; parenteral

1.7

200.4

4966

15423

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

199.9

8344

29245

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

199.7

5328

16866

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

199.6

2717

7011

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

199.4

16539

65389

SPAT1283

SPAT

Restricted health certificate

1.4

199.1

11140

41282

L86

ICPC

Back syndrome with radiating pain

1.8

198.8

3342

9268

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.5

198.3

1497

3000

N06AA12

ATC

doxepin; systemic

2.0

197.9

2447

6093

N06AB05

ATC

paroxetine; oral

1.9

197.8

3251

8950

G44.0

ICD-10 Finland

Cluster headache syndrome

4.1

196.0

696

852

L04AX01

ATC

azathioprine; systemic

2.1

195.9

2339

5746

KMAK, ,

NOMESCO Finland

1.3

195.8

31652

136963

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

195.5

3355

9365

I49.5

ICD-10 Finland

Sick sinus syndrome

2.4

195.0

1590

3310

M01AX17

ATC

nimesulide; oral

1.4

195.0

11775

44205

H53.2

ICD-10 Finland

Diplopia

2.4

194.8

1651

3501

G44.8

ICD-10 Finland

Other specified headache syndromes

3.3

194.7

936

1440

S80.0

ICD-10 Finland

Contusion of knee

1.7

194.4

4450

13525

G04BD12

ATC

mirabegron; oral

1.6

194.3

5616

18128

P99

ICPC

Psychological disorders other

2.2

193.9

1897

4293

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

193.9

7914

27596

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

193.8

15189

59488

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

193.8

1043

1727

R518, ,

ICD-10 Finland

+∞

193.3

248

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.3

193.0

918

1402

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.9

193.0

1162

2059

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.6

192.9

1343

2580

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

192.4

7032

23953

N05BA09

ATC

clobazam; oral

6.9

192.3

416

303

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

192.1

2509

6376

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

192.0

4654

14363

H57.1

ICD-10 Finland

Ocular pain

2.1

191.9

2291

5627

K92.0

ICD-10 Finland

Haematemesis

2.7

191.8

1247

2308

JN6AD

NOMESCO Finland

CT of torso and neck

3.3

191.7

898

1357

C10AA01

ATC

simvastatin; oral

1.3

191.4

19913

81264

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

190.6

908

1388

A07AA09

ATC

vancomycin; oral

3.8

190.6

753

1005

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.6

190.2

1380

2709

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.4

189.0

1648

3541

M54.1

ICD-10 Finland

Radiculopathy

2.1

189.0

2129

5110

T90

ICPC

Diabetes non-insulin dependent

1.4

188.9

12284

46665

SPAT1252

SPAT

Overall medication plan or its review

1.9

188.7

3074

8435

L14

ICPC

Leg/thigh symptom/complaint

1.7

188.7

4388

13390

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

188.7

7465

25854

E66.8

ICD-10 Finland

Other obesity

1.8

188.5

3216

8958

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

188.5

4171

12556

N05BE01

ATC

buspirone; oral

2.4

188.1

1577

3327

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

187.4

7104

24380

M02AA07

ATC

piroxicam; topical

1.3

187.1

18764

76130

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

4.3

186.5

635

750

Z00.8

ICD-10 Finland

Other general examinations

1.7

186.5

4612

14306

R07.0

ICD-10 Finland

Pain in throat

1.7

185.3

4432

13626

A10AC01

ATC

insulin (human); parenteral

1.7

184.3

3858

11430

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

184.1

17016

68212

207

Kela drug reimbursment

Chronic arrhythmias

1.5

183.3

6910

23679

R10.0

ICD-10 Finland

Acute abdomen

2.2

183.1

1825

4163

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

182.4

2512

6506

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

182.4

2754

7366

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

181.6

13901

54158

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

181.1

1098

1953

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

181.0

6804

23297

I95.9

ICD-10 Finland

Hypotension, unspecified

3.7

181.0

743

1021

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

38.2

181.0

198

G43.8

ICD-10 Finland

Other migraine

3.1

180.9

952

1554

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

180.8

43920

198815

130

Kela drug reimbursment

Malignant tumour

1.7

180.8

4161

12658

WX872

NOMESCO Finland

Intensive care

2.0

179.4

2456

6347

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

179.4

5850

19410

L16

ICPC

Ankle symptom/complaint

1.5

179.2

6857

23566

SFA30

NOMESCO Finland

Three-surface restoration

1.3

178.5

25075

106202

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.2

178.4

888

1398

L04AD02

ATC

tacrolimus; systemic

4.1

178.4

642

795

A02BC04

ATC

rabeprazole; oral

1.6

178.1

4627

14531

UJD02

NOMESCO Finland

Gastroscopy

2.0

178.1

2315

5871

M01AH02

ATC

rofecoxib; oral

1.5

177.9

5913

19702

R01AD12

ATC

fluticasone furoate; nasal

1.3

177.7

19264

78880

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

177.7

2355

6015

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.3

177.4

1682

3754

J20

ICD-10 Finland

Acute bronchitis

1.5

177.1

5840

19423

K07.60

ICD-10 Finland

Snapping jaw

1.8

176.9

3001

8340

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

176.1

2923

8067

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.4

176.0

1505

3204

M01AC06

ATC

meloxicam; systemic, rectal

1.3

175.9

19382

79513

K08.80

ICD-10 Finland

Toothache NOS

1.6

175.6

5335

17409

J46

ICD-10 Finland

Status asthmaticus

2.4

175.5

1507

3215

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

3.7

175.4

719

987

R40.2

ICD-10 Finland

Coma, unspecified

5.3

175.4

472

445

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

175.3

6851

23643

N02CC03

ATC

zolmitriptan; nasal, oral

1.9

175.2

2895

7978

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.5

175.1

765

1101

M54.3

ICD-10 Finland

Sciatica

1.8

174.8

3079

8659

J05AB11

ATC

valaciclovir; oral

1.5

174.7

7851

27866

R25.1

ICD-10 Finland

Tremor, unspecified

2.3

174.4

1556

3379

N05AB03

ATC

perphenazine; systemic, rectal

2.2

174.2

1799

4166

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

173.3

5550

18332

A11CC03

ATC

alfacalcidol; systemic

2.7

173.0

1165

2198

U05

ICPC

Urination problems other

1.9

172.6

2536

6718

L04

ICPC

Chest symptom/complaint

1.7

172.4

3489

10231

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.3

172.2

1524

3297

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.9

172.1

2507

6622

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.1

171.7

914

1503

N06AX05

ATC

trazodone; oral

2.5

171.6

1337

2721

TGC00

NOMESCO Finland

Bronchial lavation

2.6

171.5

1235

2415

M05BA04

ATC

alendronic acid; oral

1.7

171.2

3603

10686

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.3

171.0

1620

3614

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

170.7

2830

7805

J01DA09

ATC

[U] cefadroxil

1.3

170.6

15080

59945

L04AD01

ATC

ciclosporin; systemic

2.9

170.4

996

1734

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

170.4

19713

81319

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

170.3

6055

20469

WVA20

NOMESCO Finland

Medicine administration

2.3

170.3

1511

3272

G43

ICD-10 Finland

Migraine

1.8

169.8

3268

9442

R03AC03

ATC

terbutaline; inhalant

1.5

169.5

7439

26271

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

169.3

2313

5972

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

169.2

2290

5892

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

169.0

6418

22004

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

168.7

4725

15114

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

168.6

1719

3958

R06.4

ICD-10 Finland

Hyperventilation

3.1

167.8

884

1444

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

167.6

7408

26192

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

167.5

3935

12028

I20.09

ICD-10 Finland

Unstable angina

1.9

167.5

2455

6497

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.1

166.7

891

1469

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.7

166.6

668

902

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.7

166.5

1072

1973

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

166.2

1073

1978

N02CC04

ATC

rizatriptan; oral

1.8

166.0

3095

8856

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.2

165.9

1782

4194

M10.9

ICD-10 Finland

Gout, unspecified

1.8

165.5

3181

9185

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

165.3

2551

6871

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.5

164.9

716

1026

N06AX22

ATC

agomelatine; oral

2.4

164.8

1402

2977

N05AH02

ATC

clozapine; systemic

2.7

164.6

1063

1960

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

164.5

2052

5122

N05AD01

ATC

haloperidol; systemic

2.3

164.5

1554

3462

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

164.1

2418

6410

L05

ICPC

Flank/axilla symptom/complaint

1.7

164.0

3364

9901

R04.0

ICD-10 Finland

Epistaxis

1.7

163.8

3600

10804

R50.0

ICD-10 Finland

Fever with chills

60.2

163.5

168

C01CA24

ATC

epinephrine; parenteral

1.7

163.4

3482

10360

R29

ICPC

Respiratory symptom/complaint other

1.7

163.2

3743

11365

R54

ICD-10 Finland

Senility

16.3

162.6

221

G72.8

ICD-10 Finland

Other specified myopathies

3.3

162.2

771

1177

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

162.1

5600

18801

SPAT1167

SPAT

Insertion of urinary catheter

2.4

162.0

1311

2718

C08CA13

ATC

lercanidipine; oral

1.5

161.6

6793

23769

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.3

161.4

1455

3174

J01CF05

ATC

flucloxacillin; systemic

1.7

160.9

3868

11894

M54

ICD-10 Finland

Dorsalgia

1.5

160.7

7275

25830

S70.0

ICD-10 Finland

Contusion of hip

2.1

160.1

1912

4694

N02CC07

ATC

frovatriptan; oral

2.0

160.0

2243

5843

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.1

159.6

854

1409

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

159.1

12090

46918

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

158.8

2436

6546

F34.1

ICD-10 Finland

Dysthymia

2.0

158.7

2021

5084

R06AX27

ATC

desloratadine; oral

1.3

158.3

17448

71373

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

158.2

2268

5955

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

157.8

5713

19373

L13

ICPC

Hip symptom/complaint

1.4

157.8

9805

36842

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

157.8

1442

3165

N19

ICD-10 Finland

Unspecified kidney failure

2.2

157.7

1633

3784

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.8

157.4

980

1770

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

7.1

157.4

332

234

A05

ICPC

Feeling ill

1.7

157.3

3700

11308

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

157.3

1703

4020

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

157.3

1277

2652

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

157.2

1712

4051

M35.7

ICD-10 Finland

Hypermobility syndrome

3.1

157.0

832

1364

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.0

156.7

579

733

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

156.6

6094

20983

R03BA01

ATC

beclometasone; inhalant

1.5

156.2

7219

25722

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.6

156.0

660

928

D12

ICPC

Constipation

2.1

155.8

1826

4449

R01AD58

ATC

fluticasone, combinations; nasal

1.3

155.8

15299

61593

Z94.0

ICD-10 Finland

Kidney transplant status

3.8

155.7

618

828

SGA01

NOMESCO Finland

Emergency treatment

1.4

155.0

9721

36571

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.5

155.0

1231

2529

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

154.9

781

1240

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.5

154.9

667

950

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

154.9

3700

11355

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

344.5

154.6

206

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.8

154.4

976

1778

R63.1

ICD-10 Finland

Polydipsia

12.6

154.1

233

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

154.0

4020

12624

U01

ICPC

Dysuria/painful urination

1.6

153.6

4220

13423

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.6

152.5

1078

2087

J45

ICD-10 Finland

Asthma

1.5

152.1

5682

19391

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

151.7

3075

9014

S76

ICPC

Skin infection other

1.8

151.5

2739

7759

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

151.0

2067

5338

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

8.9

150.9

275

156

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.3

150.4

706

1069

M89.0

ICD-10 Finland

Algoneurodystrophy

4.3

149.8

501

583

R68.8

ICD-10 Finland

Other specified general symptoms and signs

4.8

149.5

447

469

K04.08

ICD-10 Finland

Other specified pulpit

1.6

149.4

4692

15406

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

149.2

1119

2234

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

148.9

3956

12476

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.4

148.7

674

996

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.2

148.4

1599

3767

P18

ICPC

Medication abuse

4.9

147.6

432

444

D07AA02

ATC

hydrocortisone; topical

1.4

147.6

7889

28854

A03FA02

ATC

cisapride; oral, rectal

1.7

147.1

3444

10508

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

147.1

3323

10042

E000001, ,

ATC

1.3

146.6

10959

42358

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

146.4

6163

21546

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.5

146.3

467

521

ZXD35

NOMESCO Finland

Usual procedure

2.1

146.2

1593

3770

T74.1

ICD-10 Finland

Physical abuse

2.5

146.0

1139

2319

R25.2

ICD-10 Finland

Cramp and spasm

2.3

146.0

1331

2918

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

145.9

61021

290451

A10BA02

ATC

metformin; oral

1.3

145.5

14402

57956

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

145.4

1936

4949

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.0

145.3

534

673

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

145.2

3682

11471

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

145.2

4687

15482

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

145.1

1967

5061

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

145.0

4090

13087

L84

ICPC

Back syndrome without radiat pain

1.8

144.8

2488

6935

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

144.4

1840

4628

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

144.4

3613

11218

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

144.0

2023

5272

R12

ICD-10 Finland

Heartburn

1.6

143.7

4638

15318

A06

ICPC

Fainting/syncope

3.2

143.1

715

1129

A01AB09

ATC

miconazole; local oral

1.6

142.9

4125

13272

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

8.4

142.8

269

161

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

142.7

13864

55626

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

141.8

1074

2155

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

141.6

2256

6137

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

141.6

5169

17541

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

141.5

5622

19418

K04.0

ICD-10 Finland

Pulpitis

1.5

141.5

5298

18076

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

141.3

1142

2366

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.2

141.3

389

376

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

141.2

2731

7893

A06AH03

ATC

naloxegol; oral

3.3

141.1

668

1017

7807A

ICD-9 Finland

General symptoms, Malaise and fatigue

+∞

141.0

181

R04.2

ICD-10 Finland

Haemoptysis

2.1

140.9

1562

3722

C09CA01

ATC

losartan; oral

1.3

140.7

12673

50302

C08DA01

ATC

verapamil; systemic

2.0

140.7

1866

4763

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

139.7

4542

15022

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.1

139.5

735

1201

R06.5

ICD-10 Finland

Mouth breathing

1.5

139.4

4770

15958

L04AX03

ATC

methotrexate; systemic

1.5

139.3

4957

16726

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

139.3

1969

5142

Z29

ICPC

Social problem NOS

2.4

139.1

1201

2568

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

138.9

999

1952

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

138.8

1590

3839

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.2

138.8

1343

3023

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.1

138.7

1515

3588

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

138.5

2053

5450

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.7

138.0

552

744

K90

ICPC

Stroke/cerebrovascular accident

2.4

137.8

1185

2529

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

137.7

1264

2779

A27

ICPC

Fear of other disease NOS

1.8

137.7

2473

6988

SPAT1101

SPAT

Orthostatic test

2.0

137.5

1698

4221

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

137.4

24183

104234

M54.8

ICD-10 Finland

Other dorsalgia

1.8

137.3

2421

6802

SPAT1360

SPAT

Extensive global examination

1.7

136.8

3298

10138

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.8

136.7

872

1597

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

136.5

905

1693

XA400

NOMESCO Finland

EEG

5.8

136.5

339

293

N02CC06

ATC

eletriptan; oral

1.9

136.3

1948

5106

K80

ICPC

Cardiac arrhythmia NOS

1.6

136.1

4195

13703

WW200

NOMESCO Finland

Immunization

2.2

136.1

1404

3248

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

136.0

1042

2103

OAB93, ,

SPAT

1.6

135.6

4093

13304

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.5

135.6

586

837

S21

ICPC

Skin texture symptom/complaint

1.4

135.4

8144

30365

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

135.3

1105

2301

RS221, ,

NOMESCO Finland

3.0

134.8

731

1216

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

134.7

1161

2480

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

134.6

1386

3204

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

134.2

4001

12967

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.1

133.8

1462

3463

WZC00, ,

SPAT

1.4

133.7

8596

32397

N02CC05

ATC

almotriptan; oral

1.9

133.7

2092

5656

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

133.6

4385

14530

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

133.6

1860

4831

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

133.3

910

1730

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.3

133.2

619

931

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

133.0

1522

3673

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

6.1

133.0

318

263

EB1VA, ,

NOMESCO Finland

1.3

132.9

10443

40602

N05BA02

ATC

chlordiazepoxide; systemic

2.4

132.5

1087

2268

R03BA08

ATC

ciclesonide; inhalant

1.5

132.5

4486

14967

R50.1

ICD-10 Finland

Persistent fever

132.9

132.5

185

Z50.1

ICD-10 Finland

Other physical therapy

1.8

132.2

2438

6945

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

132.2

1522

3682

C82.1

ICD-10 Finland

Follicular lymphoma grade II

6.7

132.0

293

221

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

131.7

2152

5901

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.8

131.5

2375

6721

PA2AD

NOMESCO Finland

CT angiography of brain

3.8

131.3

512

677

A10AE05

ATC

insulin detemir; parenteral

1.7

131.2

2607

7592

P01BA02

ATC

hydroxychloroquine; oral

1.6

131.2

3942

12798

N06BA04

ATC

methylphenidate; oral

1.9

130.9

2111

5763

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

130.8

1483

3565

S01

ICPC

Pain/tenderness of skin

1.8

130.8

2400

6826

ZY000

NOMESCO Finland

Hospital inpatient

3.0

130.3

735

1253

A87.9

ICD-10 Finland

Viral meningitis, unspecified

4.5

130.3

412

456

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

130.1

1524

3711

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.9

129.5

757

1318

R09

ICPC

Sinus symptom/complaint

1.5

129.4

4603

15521

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.9

129.3

758

1322

A97

ICPC

No disease

1.3

129.1

11291

44563

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.6

129.0

946

1867

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

128.9

1184

2604

N29

ICPC

Neurological sympt/complt other

2.6

128.0

934

1839

U71

ICPC

Cystitis/urinary infection other

1.6

127.8

3451

10915

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

127.7

2707

8030

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

127.4

1551

3834

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

127.2

3299

10329

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.7

127.1

837

1560

UDC00

NOMESCO Finland

Ear microscopy

1.6

126.7

3703

11939

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.4

126.5

1052

2210

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

125.8

1658

4221

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.9

125.8

474

610

R81

ICPC

Pneumonia

1.9

125.6

1865

4953

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

125.4

13784

56070

D07AC13

ATC

mometasone; topical

1.3

125.2

15824

65493

M02AA10

ATC

ketoprofen; topical

1.4

125.2

7868

29520

SPAT1053

SPAT

Memory test

1.5

125.0

5388

18893

IHZ04, ,

SPAT

2.4

124.9

1070

2279

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

124.6

4389

14763

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

7.5

124.6

254

171

XCK00

NOMESCO Finland

Perimetry

1.7

124.6

2798

8434

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

124.6

4976

17186

N04AA02

ATC

biperiden; systemic

2.5

124.5

922

1829

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

124.3

4479

15139

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.4

124.3

1053

2231

B01AB04

ATC

dalteparin; parenteral

1.8

124.2

2397

6919

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

124.2

794

1456

N06AG02

ATC

moclobemide; oral

1.9

124.0

1987

5413

205

Kela drug reimbursment

Chronic hypertension

1.3

124.0

12043

48190

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

123.9

1009

2098

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

123.8

15658

64794

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

123.7

3853

12608

P19

ICPC

Drug abuse

3.2

123.4

617

975

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

123.4

1339

3163

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.4

122.9

1025

2156

F32

ICD-10 Finland

Depressive episode

1.6

122.8

3114

9692

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.6

122.7

517

725

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.2

122.7

621

989

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.1

122.7

341

333

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

6.2

122.5

286

230

S10

ICPC

Boil/carbuncle

1.6

122.3

3128

9758

WVA20, ,

SPAT

1.9

122.1

1810

4804

C09AA02

ATC

enalapril; systemic

1.3

122.1

8831

33867

J01MA06

ATC

norfloxacin; oral

1.4

122.0

6129

22117

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

121.9

5181

18115

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.0

121.4

449

569

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

121.4

2195

6213

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

121.1

1946

5306

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

121.0

2706

8146

G40.89

ICD-10 Finland

Other epilepsy

6.5

120.8

272

209

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

120.5

1444

3547

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

120.4

21804

93903

SPAT1172

SPAT

Guidance concerning hydration

2.5

120.4

911

1827

C10AC01

ATC

colestyramine; oral

2.1

120.4

1347

3221

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

120.4

711

1246

F45.0

ICD-10 Finland

Somatization disorder

6.4

120.3

277

219

S04

ICPC

Lump/swelling localized

1.4

120.2

6068

21914

X57

ICD-10 Finland

Unspecified privation

2.3

120.0

1127

2503

P16

ICPC

Acute alcohol abuse

2.5

120.0

899

1794

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.7

119.9

775

1430

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

119.8

1117

2473

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

119.7

1948

5333

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.2

119.6

1175

2662

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

119.5

2432

7130

Z08

ICPC

Social welfare problem

2.8

119.3

718

1272

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

119.2

3723

12188

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.8

118.6

463

613

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

118.3

5487

19504

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

118.2

1458

3621

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

118.2

10130

39810

IGY02, ,

SPAT

2.5

118.1

941

1936

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

6.5

118.1

268

208

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

118.1

2438

7176

D07AD01

ATC

clobetasol; topical

1.3

117.9

8704

33466

V03AE01

ATC

polystyrene sulfonate; oral

3.1

117.8

601

962

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

117.7

1040

2247

S20.2

ICD-10 Finland

Contusion of thorax

1.7

117.7

2725

8279

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

117.6

2212

6335

RS220, ,

NOMESCO Finland

3.0

117.4

645

1082

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.5

117.2

908

1843

K29

ICPC

Cardiovascular sympt/complt other

1.8

117.1

1925

5287

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

117.0

1623

4208

IHZ05, ,

SPAT

1.7

117.0

2752

8397

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

116.9

1712

4524

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.1

116.5

1297

3095

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

116.4

3731

12284

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

116.3

4309

14644

G40.10

ICD-10 Finland

Simple partial seizures

4.3

116.2

387

449

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

116.0

1153

2625

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.2

115.7

1209

2811

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.4

115.7

995

2123

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

115.3

2330

6815

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

115.2

904

1846

B02.9

ICD-10 Finland

Zoster without complication

1.6

115.2

3144

9966

R06AX22

ATC

ebastine; oral

1.3

114.9

9271

36107

NF3AA

NOMESCO Finland

Femur X-ray examination

2.4

114.9

956

2009

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

114.8

5859

21192

SPAT1325

SPAT

Vaccination

1.2

114.6

17100

72019

H92.0

ICD-10 Finland

Otalgia

1.6

114.5

3556

11624

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

114.4

2781

8559

R06.2

ICD-10 Finland

Wheezing

1.7

114.3

2274

6621

K78

ICPC

Atrial fibrillation/flutter

1.6

114.3

3077

9720

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

114.3

8011

30548

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

114.0

1376

3389

N07

ICPC

Convulsion/seizure

10.2

113.9

191

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

6.8

113.7

248

183

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

113.0

2834

8793

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.4

112.8

910

1884

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

112.6

2383

7062

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

112.3

1137

2609

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

112.1

6875

25657

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

112.1

1244

2965

C08CA05

ATC

nifedipine; systemic

1.7

111.9

2689

8250

ZX112

NOMESCO Finland

Subcutaneous

2.4

111.8

950

2016

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

111.6

7627

28961

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

111.5

3051

9674

RS222, ,

NOMESCO Finland

3.2

111.5

559

885

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.6

111.4

762

1450

N18

ICPC

Paralysis/weakness

2.5

111.4

840

1682

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.6

111.3

771

1477

G04BD08

ATC

solifenacin; oral

1.6

111.3

2755

8518

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.8

111.2

1887

5235

U29

ICPC

Urinary symptom/complaint other

2.0

111.2

1433

3618

GD1AA, ,

SPAT

1.3

111.1

9420

36931

RD210, ,

NOMESCO Finland

2.5

111.1

864

1757

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

111.0

2756

8527

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

111.0

2569

7803

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

111.0

1375

3421

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.0

110.9

594

981

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

110.8

2465

7407

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

5.5

110.5

286

259

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

110.5

1360

3375

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

110.4

2014

5714

WX320

NOMESCO Finland

Spinalanesthesy

1.3

110.4

12496

50901

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

110.3

3176

10197

N03AX23

ATC

brivaracetam; systemic

10.0

110.2

187

J01FA15

ATC

telithromycin; oral

1.5

110.2

4825

16954

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.8

110.1

1908

5328

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

110.0

1323

3254

Z72.2

ICD-10 Finland

Drug use

4.3

110.0

370

433

SPAT1058

SPAT

PEF monitoring instruction

1.5

110.0

3746

12498

J45.8

ICD-10 Finland

Mixed asthma

2.0

109.9

1459

3724

C02AC05

ATC

moxonidine; oral

1.8

109.8

1912

5348

XA402

NOMESCO Finland

ENMG

2.2

109.7

1172

2751

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.5

109.6

871

1790

B02AA02

ATC

tranexamic acid; systemic

1.4

109.6

7631

29055

N06DX01

ATC

memantine; oral

1.6

109.5

2713

8390

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

8.1

109.4

211

131

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.4

109.3

924

1956

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.8

109.3

675

1214

L09

ICPC

Arm symptom/complaint

1.7

109.2

2541

7729

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.8

109.0

658

1168

N05CD08

ATC

midazolam; nasal, systemic

2.3

108.9

971

2107

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.3

108.9

1025

2279

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

108.8

3103

9939

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

108.7

2203

6448

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

108.6

636

1109

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.4

108.6

872

1801

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.6

108.5

797

1575

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

108.4

719

1346

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

108.4

1894

5303

N28

ICPC

Limited function/disability (N)

2.6

108.3

754

1449

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

108.2

2898

9141

T82

ICPC

Obesity

1.7

108.0

2320

6904

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.0

108.0

308

309

WX704

NOMESCO Finland

Intubation

1.5

107.8

4246

14606

R68.2

ICD-10 Finland

Dry mouth, unspecified

4.1

107.8

383

470

SPAT1139

SPAT

Nutrition survey

2.0

107.5

1489

3859

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.3

107.4

1022

2283

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.9

107.4

412

538

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.4

107.2

863

1785

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

107.2

1294

3188

R63.0

ICD-10 Finland

Anorexia

6.3

106.4

248

199

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

106.4

3209

10413

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

106.3

3408

11217

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

106.2

1434

3682

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

106.2

3290

10743

M01AB55

ATC

diclofenac, combinations; oral

1.6

106.1

2771

8683

F29

ICPC

Eye symptom/complaint other

1.4

106.1

5645

20553

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.9

106.0

1668

4516

J01DA06

ATC

[U] cefuroxime

1.4

105.8

7296

27724

A12AA04

ATC

calcium carbonate; oral

2.7

105.7

700

1309

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.0

105.7

1312

3266

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

105.7

3415

11258

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.1

105.7

1234

3001

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.9

105.6

1503

3932

A02BA04

ATC

nizatidine; systemic

1.6

105.5

3243

10570

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

105.3

5667

20673

R30.0

ICD-10 Finland

Dysuria

1.7

105.3

2225

6590

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

105.3

1642

4432

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

105.1

1257

3085

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

105.1

3370

11091

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

105.0

5522

20062

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.1

105.0

1213

2938

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

104.9

1344

3386

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

104.8

1423

3662

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

104.6

3257

10646

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.1

104.6

369

450

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

104.6

1581

4223

L50.9

ICD-10 Finland

Urticaria, unspecified

1.7

104.4

2052

5952

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.2

104.2

1003

2252

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

104.0

1394

3570

C03AA03

ATC

hydrochlorothiazide; oral

1.5

104.0

3694

12434

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.5

103.8

788

1583

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.2

103.8

286

277

N03AB02

ATC

phenytoin; systemic

3.3

103.8

489

743

R75

ICPC

Sinusitis acute/chronic

1.7

103.7

2502

7683

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

103.6

2667

8327

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.9

103.5

1455

3790

XG466

NOMESCO Finland

Sleep oxymetry

2.0

103.2

1370

3497

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.5

103.1

819

1683

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

102.9

12132

49607

SAA04

NOMESCO Finland

Special examination of mouth

1.6

102.3

2683

8416

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

102.2

1386

3565

N76.0

ICD-10 Finland

Acute vaginitis

1.5

102.0

3599

12094

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

102.0

1171

2829

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

101.9

8276

32214

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.2

101.9

1043

2405

A06AC51

ATC

ispaghula, combinations; oral

1.7

101.9

2177

6468

Y96.9

ICD-10 Finland

Unspecified type of accident

2.3

101.8

939

2069

R1250

NOMESCO Finland

Evaluation of functional capability

2.1

101.7

1180

2862

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

101.7

6933

26290

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

101.6

1708

4723

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

101.3

1662

4560

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.4

101.3

821

1704

P25

ICPC

Phase of life problem adult

1.7

100.9

2400

7340

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.5

100.9

448

653

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.2

100.8

1063

2481

-50

ICPC

Medication/prescr/renewal

1.8

100.7

1772

4972

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

100.3

3895

13354

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

100.2

5988

22228

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

100.0

793

1628

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.2

99.8

961

2158

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.6

99.8

311

340

D07AB08

ATC

desonide; topical

1.4

99.8

5518

20216

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

99.7

2627

8249

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

99.6

1672

4622

137

Kela drug reimbursment

Uraemia requiring dialysis

3.6

99.5

422

595

R5599

NOMESCO Finland

Other rehabilitation service

2.0

99.5

1266

3181

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.2

99.4

1061

2489

SPAT1281

SPAT

Other administrative function

1.5

99.4

3793

12958

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.7

99.3

634

1162

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.6

99.3

306

331

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

99.1

964

2175

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

99.0

2497

7755

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.7

99.0

402

549

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.6

98.8

417

586

PD5AD

NOMESCO Finland

CT of aorta

2.1

98.6

1060

2494

C05AA08

ATC

fluocortolone; rectal, topical

1.4

98.5

6487

24456

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

98.5

1825

5202

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011412) CD3 cells [#/volume] in Blood

1308

1778

3.73

323.31

2.6

2.2

1210.66

1207.72

e6/l

0.03

1134

1541

(3007930) Methemoglobin/Hemoglobin.total in Blood

3769

9234

2.10

320.83

6.1

4.6

0.87

0.89

2.17

3585

8698

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3462

8195

2.17

320.80

2.8

2.1

93.47

93.66

0.16

3333

7860

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2586

5367

2.46

320.70

2.6

2.0

0.00

g/l

-0.00

2425

5022

(3024980) IgG subclass 4 [Mass/volume] in Serum

2109

3936

2.73

320.62

1.7

1.5

0.73

0.79

g/l

1.46

1644

3076

(3024928) Oxygen saturation in Venous blood

2618

5472

2.45

319.99

4.3

2.8

62.65

63.00

0.30

2515

5291

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1102

1315

4.25

319.95

1.9

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1102

1315

4.25

319.95

1.9

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1102

1315

4.25

319.95

1.9

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

6442

19118

1.75

312.65

1.4

1.3

246.01

249.31

u/ml

0.05

5997

17864

(40761535) Cells panel - Urine sediment

6184

18174

1.77

310.04

4.0

3.0

0.86

1.88

—

(3044889) 12 lead EKG panel

47357

197702

1.57

307.65

4.5

3.5

0.41

3312.65

1.35

360

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3879

8160

2.46

307.65

2.5

2.1

3.71

3.75

g/l

0.60

3600

7465

(3041096) Erythrocytes [Presence] in Urine by Automated

22618

85110

1.48

307.65

3.9

2.7

0.18

0.22

estimate

0.21

7661

23728

(3002030) Lymphocytes/Leukocytes in Blood

40236

134083

2.13

307.65

8.3

5.6

27.57

28.81

86.35

38656

127046

(3023420) DNA double strand Ab [Units/volume] in Serum

4517

10606

2.21

307.65

2.1

1.7

8.15

6.95

iu/ml

1.27

1088

2411

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

3641

4859

3.90

307.65

1.4

1.2

543.37

541.10

mg/l

0.03

3498

4655

(3020891) Body temperature

4485

9972

2.33

307.65

5.4

4.1

36.94

36.89

°c

9.29

4439

9883

(3020779) Urea [Moles/volume] in Serum or Plasma

9023

19694

2.48

307.65

9.9

6.4

9.37

9.44

mmol/l

0.32

8705

18768

(3003396) Base excess in Arterial blood by calculation

10816

26309

2.24

307.65

8.6

7.6

0.99

0.79

mmol/l

4.84

8934

21610

(3014576) Chloride [Moles/volume] in Serum or Plasma

12992

31666

2.28

307.65

8.7

6.8

104.13

104.66

mmol/l

24.98

12985

31652

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

11055

29649

2.02

307.65

3.5

2.4

8.33

8.37

umol/l

0.06

9594

25849

(3013826) Glucose [Moles/volume] in Serum or Plasma

47622

156745

2.51

307.65

6.7

4.1

6.61

6.65

mmol/l

3.50

45758

145592

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3216

4495

3.70

307.65

1.8

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

4339

9710

2.32

307.65

1.3

1.2

0.84

0.94

u/ml

0.19

356

718

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

6397

12478

2.72

307.65

5.3

3.4

24.26

24.08

mmol/l

3.91

6314

12311

(3017181) Myelocytes/Leukocytes in Blood

8552

22231

2.05

307.65

5.2

4.0

0.95

0.90

0.86

3086

5364

(3017143) Hepatitis C virus Ab [Presence] in Serum

12252

36315

1.83

307.65

1.8

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

20775

71459

1.64

307.65

3.2

2.3

337.66

338.76

umol/l

0.73

18574

63911

(3008152) Bicarbonate [Moles/volume] in Arterial blood

5759

13974

2.16

307.65

7.8

6.4

24.47

24.46

mmol/l

0.04

5534

13342

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

10897

26476

2.25

307.65

8.6

7.7

5.07

5.10

kpa

2.98

10526

25456

(3010421) pH of Blood

3303

6619

2.57

307.65

4.1

3.1

7.41

0.44

3257

6521

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

17409

33929

3.06

307.65

2.2

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

5977

14572

2.15

307.65

11.2

10.1

0.65

0.63

2.29

5940

14510

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

15749

54597

1.57

307.65

1.8

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

56435

214585

2.42

307.65

11.3

6.6

79.98

77.11

u/l

31.29

54528

202912

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

35871

133218

1.69

307.65

3.3

2.5

—

estimate

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

23330

67039

2.09

307.65

3.6

2.8

1378.32

1208.80

ng/l

5.45

20047

56499

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2920

4601

3.27

307.65

1.5

1.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

8186

21076

2.06

307.65

4.9

3.9

0.74

0.67

1.22

2953

5092

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2767

4469

3.18

307.65

1.5

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1206

1375

4.45

307.65

1.3

1.2

2.01

2.12

mmol/l

1.44

1128

1284

(3027945) Reticulocytes/Erythrocytes in Blood

10624

25730

2.25

307.65

3.1

2.3

1.82

1.72

14.98

9631

22826

(3033658) Prothrombin time (PT) actual/Normal

21878

66811

1.92

307.65

5.4

3.4

90.33

91.49

8.76

21355

65243

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3265

6365

2.64

307.65

3.8

2.9

0.34

0.35

iu/ml

0.52

1829

3349

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

49164

207731

1.57

307.65

4.3

2.9

53.07

42.27

u/l

94.57

46852

196762

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

14147

40746

1.92

307.65

3.7

2.6

2.96

2.88

e6/l

0.28

7206

18592

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

6117

15083

2.13

307.65

10.9

9.8

1.40

1.30

8.31

6079

15002

(3045414) Leukocytes [Presence] in Urine

8136

24760

1.73

307.65

2.3

1.9

0.02

0.03

estimate

0.22

1715

5315

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

54800

229717

1.79

307.65

5.1

4.1

14.70

14.64

pmol/l

6.82

51404

211852

(3030467) Casts [#/volume] in Urine by Automated count

24516

71130

2.10

307.65

4.0

2.8

0.38

0.39

e6/l

0.20

18832

49648

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

3017

4883

3.18

307.65

1.3

1.2

56.99

39.39

u/ml

0.77

101

(3007164) IgA [Mass/volume] in Serum or Plasma

18741

58480

1.81

307.65

1.6

1.4

2.37

2.33

g/l

1.36

12348

36628

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

2826

4590

3.17

307.65

1.3

269.33

242.58

u/ml

4.04

1814

2925

(3036489) Thrombin time

4042

9575

2.18

307.65

2.5

1.9

20.99

20.83

0.70

3572

8353

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

3327

7075

2.42

307.65

2.6

2.2

0.70

0.79

g/l

0.61

2926

6088

(3048689) Calprotectin [Mass/mass] in Stool

12573

38393

1.77

307.65

2.7

2.6

136.44

123.72

ug/g

2.58

10090

30718

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

4143

10084

2.12

307.65

5.8

4.4

1.70

1.65

2.08

3942

9524

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1467

2167

3.44

307.65

1.1

44.10

82.22

au/ml

0.92

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

21507

55234

2.35

307.65

2.1

1.6

1.14

1.17

mg/l

0.44

16657

42126

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

4280

6668

3.35

307.65

2.4

2.2

472.26

653.38

ug/l

1.49

4034

6258

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

7320

17427

2.23

307.65

2.6

2.0

6.81

8.21

ug/l

4.51

6397

15391

(44790049) Parainfluenza type 3 nucleic acid detection

1631

2440

3.40

307.65

1.6

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

3218

6471

2.56

307.65

3.6

3.1

65.43

63.01

mg/l

0.05

2720

5514

(42870588) Differential panel, method unspecified - Blood

30000

89613

2.15

307.65

7.9

5.7

5.69

5.36

0.09

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

16053

48138

1.86

307.65

3.3

2.7

2.45

2.44

mmol/l

6.35

14509

42924

(3003458) Phosphate [Moles/volume] in Serum or Plasma

13054

30075

2.43

307.65

7.7

5.2

1.05

1.04

mmol/l

4.75

12371

27815

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

723

527

6.93

307.65

2.6

2.5

51.95

50.24

umol/l

0.50

647

452

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

3218

6456

2.57

307.65

3.5

3.1

44.46

41.00

mg/l

0.33

2720

5497

(44790047) Parainfluenza type 1 nucleic acid detection

1631

2443

3.40

307.65

1.6

1.4

—

(3013115) Eosinophils [#/volume] in Blood

43873

146141

2.27

307.65

8.4

5.7

0.19

e9/l

2.46

39232

127216

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3052

3857

4.09

307.65

6.4

5.4

3082.34

699.92

iu/ml

0.88

435

537

(3013512) EKG study

24702

87504

1.63

307.65

4.0

3.1

0.75

0.74

0.09

218

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

33205

117996

1.75

307.65

2.3

1.9

95.62

97.35

pmol/l

8.21

18965

62043

(3013650) Neutrophils [#/volume] in Blood by Automated count

46644

158858

2.31

307.65

12.8

7.9

4.14

4.07

e9/l

8.57

41563

136169

(3048929) Epstein Barr virus Ab [Presence] in Serum

4378

9031

2.52

307.65

1.3

1.2

—

(3019225) pH of Specimen

7612

22685

1.76

307.65

5.3

3.4

7.37

7.35

10.50

5969

15377

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2332

3617

3.30

307.65

1.5

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

22492

84512

1.48

307.65

3.3

2.5

0.07

0.13

393

1671

(3009466) Valproate [Moles/volume] in Serum or Plasma

1971

2665

3.78

307.65

5.8

5.5

364.32

367.63

umol/l

0.36

1754

2299

(44816559) Phosphatidylethanol [Mass/volume] in Blood

4715

11961

2.04

307.65

2.0

1.7

0.33

0.28

mg/l

6.21

2340

5726

(44790048) Parainfluenza type 2 nucleic acid detection

1631

2443

3.40

307.65

1.6

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

20342

54796

2.19

307.65

3.2

2.4

5.89

5.59

e6/l

1.42

18797

49292

(3000494) Fungus identified in Specimen by Culture

10414

32908

1.68

307.65

1.6

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

9187

20026

2.48

307.65

8.5

7.8

1.37

1.33

mmol/l

2.39

9015

19632

(36304419) Bacteria [Presence] in Urine

23338

68362

2.05

307.65

3.8

2.7

59.21

164.04

estimate

0.47

307

(3000570) Elastase.pancreatic [Mass/mass] in Stool

3305

6503

2.62

307.65

1.5

1.4

274.51

281.80

ug/g

0.89

1892

3691

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2763

5751

2.46

307.65

2.5

2.0

0.00

g/l

0.23

2430

5037

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

20258

66056

1.74

307.65

2.9

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

8298

19093

2.33

307.65

3.1

2.3

70.70

69.26

e9/l

2.31

6152

13759

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

6760

17544

2.02

307.65

4.8

3.6

95.68

84.46

ng/l

11.88

5944

15309

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2887

4574

3.25

307.65

1.5

1.4

24.58

19.55

u/ml

0.69

(3015736) pH of Urine

33853

121811

1.73

307.65

4.1

3.0

6.25

6.19

15.86

19172

68504

(3020564) Creatinine [Moles/volume] in Serum or Plasma

67568

316203

2.00

307.65

28.7

14.6

78.01

75.28

umol/l

58.77

67101

312197

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

7843

15137

2.79

307.65

1.9

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3414

7695

2.28

307.65

3.2

2.3

3.56

3.61

g/l

0.78

3273

7367

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

41713

126362

2.53

307.65

9.4

5.9

1.21

mmol/l

29.74

36738

108338

(3021901) Oxygen saturation in Capillary blood

2315

4241

2.79

307.65

3.2

2.8

90.49

90.45

0.09

2257

4110

(3015377) Calcium [Moles/volume] in Serum or Plasma

28077

88748

1.95

307.65

4.1

3.0

2.35

2.36

mmol/l

29.25

25977

80934

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

2227

2785

4.10

307.65

1.9

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

66329

294790

2.46

307.65

26.2

13.0

139.40

139.78

mmol/l

274.18

65612

287943

(3019977) pH of Arterial blood

10907

26502

2.25

307.65

8.7

7.7

7.42

7.41

5.11

6172

13889

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

13055

24360

3.05

307.65

2.0

1.5

—

(3019069) Monocytes/Leukocytes in Blood

39625

129417

2.17

307.65

8.3

5.8

8.75

8.71

1.81

37777

121240

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

54120

211173

2.11

307.65

5.4

3.7

12.32

10.43

mm/h

148.61

51477

197838

(3012501) Base excess in Blood by calculation

2354

4093

2.94

307.65

4.3

3.5

2.40

2.50

mmol/l

0.69

1582

2668

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3887

8188

2.45

307.65

2.5

2.1

7.37

7.29

g/l

1.83

3603

7478

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

5721

12457

2.41

307.65

4.0

3.1

1.67

1.64

mmol/l

0.22

4205

8961

(1616796) Gas panel - Central venous blood

2542

4565

2.85

307.65

4.0

3.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3972

8155

2.52

307.65

2.3

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

6639

14829

2.37

307.65

4.2

3.2

5.13

kpa

0.06

6365

14097

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

28584

71228

2.66

307.65

2.6

1.9

204.44

217.97

u/l

0.90

27401

66873

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

14160

35126

2.27

307.65

3.1

2.3

22.65

23.52

9.09

13263

32561

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11547

38516

1.60

307.65

2.1

1.7

1.54

1.38

75.48

10138

34582

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

5316

11010

2.53

307.65

4.0

2.5

0.63

0.62

0.59

5294

10982

(3009261) Glucose [Presence] in Urine by Test strip

41381

154933

1.78

307.65

4.7

3.3

0.28

0.17

estimate

0.27

8976

28748

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3883

8178

2.46

307.65

2.5

2.1

4.20

4.25

g/l

3.25

3606

7480

(3001122) Ferritin [Mass/volume] in Serum or Plasma

38436

143350

1.73

307.65

3.8

2.9

132.56

105.32

ug/l

48.40

36329

134958

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3692

7391

2.58

307.65

2.1

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

23086

67193

2.06

307.65

2.6

2.2

2.80

2.72

mg/l

4.84

20317

57715

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2876

5682

2.60

307.65

3.4

3.0

4.07

6.35

ratio

0.46

1688

3174

(3019309) Folate [Moles/volume] in Red Blood Cells

13846

38262

2.00

307.65

1.8

1.7

1181.46

1151.88

nmol/l

2.81

10951

28935

(3004789) Transferrin [Mass/volume] in Serum or Plasma

15257

38691

2.23

307.65

3.0

2.3

2.32

2.39

g/l

39.64

14241

35569

(3018677) aPTT in Platelet poor plasma by Coagulation assay

14939

34359

2.48

307.65

2.5

1.9

29.61

29.57

0.30

14535

33413

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

4845

9744

2.60

307.65

2.2

1.9

39.84

39.71

u/l

0.14

4395

8737

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

3193

4252

3.89

307.65

1.4

34.71

28.13

e6/l

0.40

2383

3107

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2318

4364

2.71

307.65

1.7

1.5

—

(3017732) Neutrophils [#/volume] in Blood

10965

34488

1.70

307.65

3.6

2.8

4.46

e9/l

0.01

9657

30159

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

66949

315140

1.81

307.65

16.2

9.7

27.26

26.70

u/l

6.19

65740

306137

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

28862

81667

2.28

307.65

3.4

2.3

62.19

70.35

u/l

0.49

27132

75396

(3022948) Iron [Moles/volume] in Serum or Plasma

16143

42127

2.18

307.65

3.0

2.3

13.04

14.44

umol/l

2.39

15172

39245

(3006504) Eosinophils/Leukocytes in Blood

39520

129092

2.17

307.65

8.3

5.7

2.75

2.89

28.61

37645

120832

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3812

6823

2.90

307.65

2.0

1.6

0.23

g/l

0.86

3651

6530

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3894

7072

2.86

307.65

1.9

1.6

1.20

1.18

g/l

3.00

3736

6790

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

3125

6695

2.40

307.65

1.4

1.2

—

(40768797) Stomach Pathology biopsy report

12051

34893

1.87

307.65

1.3

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

37617

112048

2.41

307.65

8.5

5.5

1.21

mmol/l

28.82

35543

103031

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1511

2215

3.47

307.65

1.1

33.44

17.99

au/ml

0.42

(3018418) pH of Serum or Plasma

26001

73321

2.21

307.65

5.3

3.6

7.40

1.51

19137

50404

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

3302

7018

2.42

307.65

2.7

2.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

3114

6107

2.62

307.65

1.5

12.22

14.52

iu/ml

0.34

133

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2297

3600

3.27

307.65

1.4

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

28456

95427

1.81

307.65

4.1

2.9

34.77

32.26

u/l

2.35

27085

90201

(3007853) Bacteria identified in Skin by Aerobe culture

11299

30305

2.03

307.65

2.0

1.6

—

(4035726) Immunohistochemistry procedure

7165

21156

1.77

307.65

1.5

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

43531

145003

2.26

307.65

8.1

5.6

1.90

1.96

e9/l

10.11

39176

127324

(40760888) Immunoglobulin light chains.free panel - Serum

2230

4138

2.75

307.65

3.5

3.2

1027.07

0.88

—

(3002582) Erythrocytes [#/volume] in Urine

28181

82977

2.14

307.65

4.1

2.8

68.97

92.57

e6/l

1.82

22434

60850

(3002032) Base excess in Venous blood by calculation

10096

21018

2.63

307.65

5.2

3.2

1.82

1.63

mmol/l

4.83

8915

18208

(3012095) Magnesium [Moles/volume] in Serum or Plasma

16654

37960

2.55

307.65

4.4

3.0

0.81

0.82

mmol/l

29.50

15862

35626

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

3287

4255

4.00

307.65

1.3

1.2

3.72

3.73

mmol/l

0.21

3123

4034

(3018095) Leukocytes [#/volume] in Urine

31158

99547

1.99

307.65

4.9

3.3

84.36

94.17

e6/l

0.94

23441

65611

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3273

4740

3.57

307.65

1.8

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

4584

9634

2.48

307.65

1.9

1.7

1.53

1.48

g/l

2.84

3977

8235

(3002173) Hemoglobin [Mass/volume] in Arterial blood

9035

22243

2.18

307.65

9.6

8.4

121.38

122.70

g/l

6.22

8845

21706

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

2647

4281

3.18

307.65

1.5

1.4

146.53

149.48

au/ml

0.49

724

1277

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

20504

69815

1.66

307.65

1.4

1.3

1.55

1.72

u/ml

1.12

5740

19635

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

4876

10448

2.43

307.65

4.9

3.2

49.32

47.62

4.01

4818

10293

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

31788

92855

2.27

307.65

4.5

2.8

48.90

66.07

ng/l

1.06

21631

57183

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

12242

23274

2.96

307.65

2.1

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

51009

195157

2.04

307.65

5.7

3.8

12.21

2.41

0.47

302

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

9202

23947

2.06

307.65

3.2

2.2

35.45

51.66

u/l

2.64

7929

20234

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

62370

280834

1.79

307.65

21.3

11.2

85.27

84.96

ml/min/173m2

2.79

58671

254541

(3036481) Cortisol [Moles/volume] in Serum or Plasma

11042

21353

2.87

307.65

2.4

2.2

371.17

382.63

nmol/l

5.97

10343

19832

(3023103) Potassium [Moles/volume] in Serum or Plasma

66369

295560

2.44

307.65

26.4

13.1

3.96

mmol/l

0.57

65575

288091

(3022096) Basophils/Leukocytes in Blood

39453

129167

2.16

307.65

8.3

5.8

0.67

0.69

16.34

37570

120731

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

5677

13582

2.19

307.65

10.6

9.9

24.29

24.18

mmol/l

1.66

5561

13299

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

11588

25039

2.57

307.65

5.3

3.8

242.16

239.62

u/l

0.66

11085

23737

(3014007) Fractional oxyhemoglobin in Arterial blood

6152

15085

2.14

307.65

11.0

10.0

93.85

94.10

1.96

6131

15041

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

9306

22469

2.23

307.65

2.7

2.2

0.21

0.22

g/l

17.83

8675

21058

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1394

1692

4.19

307.65

1.9

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3673

7725

2.45

307.65

2.5

2.1

2.93

2.82

g/l

7.53

3392

7019

(3027801) Oxygen [Partial pressure] in Arterial blood

10889

26465

2.25

307.65

8.6

7.7

12.38

12.81

kpa

11.31

10503

25445

(3029937) Albumin [Presence] in Urine by Test strip

23324

81230

1.64

307.65

4.9

3.4

0.01

0.00

estimate

0.50

8722

27461

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

6913

18473

1.97

307.65

4.8

3.3

1.22

1.23

mmol/l

10.24

6170

15563

(3016502) Oxygen saturation in Arterial blood

9681

23565

2.22

307.65

9.0

8.1

95.58

95.77

1.68

9374

22745

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6508

17052

2.00

307.65

3.3

2.6

196.93

181.35

ng/l

1.62

5914

15521

(3023183) Ammonium ion [Moles/volume] in Plasma

2788

3852

3.73

307.65

3.2

2.4

34.16

34.20

umol/l

0.02

2544

3468

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3346

7034

2.45

307.65

2.4

2.1

10.12

10.21

g/l

0.43

3034

6264

(3018405) Lactate [Moles/volume] in Arterial blood

3109

6783

2.35

307.65

4.4

3.9

1.38

1.40

mmol/l

0.38

3046

6667

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

6504

16892

2.02

307.65

1.3

43.60

53.72

au/ml

2.94

327

1158

(3024561) Albumin [Mass/volume] in Serum or Plasma

37221

115064

2.27

307.65

6.5

4.3

35.54

36.45

g/l

147.88

35280

107553

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

31012

116552

1.58

307.65

4.6

3.1

0.40

0.44

estimate

0.07

7804

24398

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

5339

13684

2.03

307.65

11.1

9.6

16.05

16.28

5.86

5168

13170

(3009343) pH of Capillary blood

6422

14446

2.34

307.65

4.2

3.2

7.41

7.42

0.69

5491

11730

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1498

1558

4.89

307.65

1.4

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2354

4095

2.94

307.65

4.3

3.5

5.01

5.00

kpa

0.39

2304

3995

(3028626) Oxygen [Partial pressure] in Capillary blood

2871

5492

2.68

307.65

3.9

3.1

8.44

kpa

0.00

2802

5352

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

16249

53619

1.67

307.65

1.8

1.6

31795089.08

38415685.75

pmol/l

0.67

13908

45042

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1261

1558

4.11

307.65

2.0

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2499

2773

4.64

307.65

3.2

2.5

7657.91

747.48

u/ml

0.98

141

114

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2297

3599

3.27

307.65

1.4

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

4357

6986

3.26

307.65

2.1

1.8

1.99

2.44

ug/l

0.78

3903

6167

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3682

7456

2.55

307.65

3.3

2.6

24.60

24.64

mmol/l

0.24

3610

7315

(3001604) Monocytes [#/volume] in Blood

42818

140888

2.27

307.65

8.1

5.6

0.58

0.57

e9/l

8.45

37781

120708

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1847

2713

3.47

307.65

1.5

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

6967

18351

2.00

307.65

2.5

2.3

20.56

21.18

au/ml

0.23

709

2346

(3026782) Osmolality of Urine

17482

46072

2.19

307.65

3.4

2.5

519.99

549.85

mosm/kgh2o

48.58

15659

39955

(3019150) Specific gravity of Urine by Refractometry

18797

68078

1.52

307.65

4.7

3.4

1.10

1.11

kg/l

0.06

12788

43433

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

3227

5893

2.82

307.65

2.2

2.0

11.83

10.94

mg/l

3.76

3038

5557

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

17411

44988

2.23

307.65

4.5

3.1

262.03

635.11

ng/l

19.88

12603

32967

(3042936) Bacteria identified in Isolate by Culture

13523

34896

2.16

307.65

2.3

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

8228

24371

1.78

307.65

4.1

2.8

—

(3003181) Sodium [Moles/volume] in Urine

1966

3175

3.16

307.65

1.5

1.4

60.78

64.53

mmol/l

2.58

1564

2469

(3021960) Folate [Moles/volume] in Serum or Plasma

22994

70629

1.92

307.65

1.8

1.6

19.55

20.30

nmol/l

11.08

20295

60195

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1588

2065

3.91

307.65

1.6

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1684

2467

3.48

307.65

7.0

5.6

11.58

11.35

mg/l

0.93

1556

2299

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

30693

91792

2.17

307.65

4.2

2.9

1.84

1.87

e6/l

0.02

(3012544) pH of Venous blood

10422

22054

2.60

307.65

5.1

3.3

7.38

0.06

6242

12273

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2272

3806

3.05

307.65

1.5

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

6110

13391

2.40

307.65

4.2

2.8

128.97

131.60

g/l

12.90

5953

13048

(3024354) Oxygen [Partial pressure] in Venous blood

8584

17938

2.58

307.65

4.4

2.7

4.64

4.62

kpa

0.40

8349

17442

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

15334

44365

1.93

307.65

3.5

2.5

1.29

1.04

e6/l

0.72

8421

22295

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

6882

15065

2.42

307.65

9.1

8.1

24.82

24.68

mmol/l

2.10

6836

14961

(3023410) Appearance of Cerebral spinal fluid

1458

1941

3.82

307.65

1.6

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

66610

294491

2.59

307.65

24.0

11.0

23.12

23.70

mg/l

4.38

58926

232364

(3037522) Nuclear Ab [Titer] in Serum

14223

37520

2.12

307.65

1.5

1.3

494.23

539.92

titre

1.83

2937

7529

(3023368) Bacteria identified in Blood by Culture

26594

60951

2.87

307.65

5.4

3.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

49930

182905

2.17

307.65

5.8

3.8

1766.30

1493.56

e6/l

0.39

719

2528

(3011397) Hemoglobin [Presence] in Urine by Test strip

19236

67680

1.58

307.65

4.4

3.2

0.23

0.29

0.24

133

637

(3021440) Promyelocytes/Leukocytes in Blood

8101

21490

2.00

307.65

5.2

4.1

0.12

0.10

1.13

2646

4646

(3021447) Carbon dioxide [Partial pressure] in Venous blood

10355

21594

2.63

307.65

5.1

3.2

5.84

5.80

kpa

3.00

10089

21050

(3021601) Nitrite [Presence] in Urine by Test strip

40840

151782

1.79

307.65

4.6

3.2

0.00

estimate

0.53

9300

29697

(40767503) Oxygen content in Capillary blood by calculation

2325

4117

2.89

307.65

2.8

2.4

16.61

16.92

3.86

2285

4014

(3018010) Neutrophils/Leukocytes in Blood

39541

131516

2.11

307.65

8.1

5.6

57.48

56.63

35.12

38224

125575

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4038

7922

2.64

307.65

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

16033

52769

1.67

307.65

1.4

1.3

31.32

34.56

iu/ml

0.55

4627

16093

(46235355) HIV 1 and 2 tests - Meaningful Use set

18978

64970

1.63

307.65

2.1

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

2020

3390

3.04

307.65

1.2

1.1

1.20

1.15

0.07

224

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

61640

273986

1.83

307.65

6.3

4.9

1.84

1.87

mu/l

2.58

58420

255479

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

3007

6278

2.46

307.65

1.9

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

1631

2441

3.40

307.65

1.6

1.4

—

(3032080) INR in Blood by Coagulation assay

38096

113425

2.43

307.65

15.2

12.0

1.22

1.23

inr

1.69

32675

92853

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4695

9196

2.66

307.65

1.6

1.5

13.46

14.20

iu/ml

0.10

126

268

(3021589) Normoblasts [#/volume] in Blood

34601

127635

1.68

307.65

14.8

9.1

0.00

e9/l

1.57

28522

103488

(3009508) Creatinine [Moles/volume] in Urine

24836

97130

1.43

307.65

3.9

3.3

7.62

7.98

mmol/l

24.51

21495

83202

(3005719) IgG [Mass/volume] in Serum or Plasma

8742

17974

2.63

307.65

3.0

2.5

10.38

10.79

g/l

12.24

8173

16543

(3035350) Ketones [Presence] in Urine by Test strip

41237

153676

1.79

307.65

4.7

3.2

5.18

2.58

estimate

2.19

9428

30201

(3028271) Lactate [Moles/volume] in Capillary blood

1818

2801

3.31

307.65

2.0

1.6

1.74

1.73

mmol/l

0.10

1784

2708

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2905

6011

2.48

307.65

2.5

2.0

0.03

0.02

g/l

1.47

2629

5404

(3028026) IgM [Mass/volume] in Serum or Plasma

6807

13975

2.59

307.65

2.0

1.8

1.28

1.30

g/l

0.31

6359

12867

(3027273) Bicarbonate [Moles/volume] in Venous blood

4390

9495

2.40

307.65

4.4

2.9

25.25

25.19

mmol/l

0.49

4255

9144

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

6126

17534

1.82

307.65

3.4

3.6

4.48

4.59

pmol/l

11.08

5520

15917

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

14881

48342

1.68

307.65

1.4

1.3

9.57

10.64

u/ml

0.76

5895

19578

(3006315) Basophils [#/volume] in Blood

42912

141235

2.27

307.65

8.1

5.6

0.04

e9/l

5.57

37835

120970

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1637

2212

3.77

307.65

1.6

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

3264

5309

3.18

307.65

1.4

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

8073

17063

2.54

307.65

2.8

2.4

66.14

67.02

g/l

16.94

7526

15630

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

43727

137623

2.48

307.65

8.5

5.2

10.94

11.65

umol/l

20.75

41971

130332

(3030981) Hyaline casts [#/volume] in Urine by Automated count

7435

19968

1.96

307.65

2.9

2.2

0.41

0.38

e6/l

0.33

7106

19002

(3027315) Oxygen [Partial pressure] in Blood

2369

4118

2.94

307.65

4.3

3.6

8.75

8.80

kpa

0.52

2319

4017

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

60746

280074

1.53

307.65

5.4

4.6

5.93

5.84

mmol/l

48.75

56804

260450

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

3241

4299

3.90

307.65

1.5

1.4

1219.29

2371.49

e6/l

0.64

2576

3326

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

35158

127439

1.74

307.65

2.8

2.3

75.11

778.25

nmol/l

0.50

32613

116814

(40758558) Short blood count panel - Blood

24228

82656

1.70

307.65

8.4

5.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

5385

11104

2.54

307.65

4.0

2.5

1.34

1.25

5.59

5357

11059

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7883

24240

1.70

307.65

4.4

4.2

26.96

25.95

ug/l

0.07

6385

19286

(3025159) Blasts/Leukocytes in Blood

8176

21792

1.99

307.65

5.4

4.3

0.27

0.25

0.05

2553

4441

(3004809) Band form neutrophils/Leukocytes in Blood

1838

3254

2.88

306.37

3.7

3.0

1.56

1.46

0.48

1686

2856

(3025941) Bacteria identified in Stool by Culture

5323

15075

1.83

300.52

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

59502

274748

1.47

299.74

6.8

5.6

39.16

38.53

mmol/mol

44.81

56375

259175

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3403

8225

2.12

299.18

4.5

3.3

24.69

24.73

mmol/l

0.35

3161

7591

(3037756) Immunofixation for Serum or Plasma

2015

3834

2.68

295.47

1.7

1.6

—

(40768795) Lymph node Pathology biopsy report

1224

1697

3.66

294.84

1.3

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

850

860

5.00

294.81

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

3497

8599

2.09

294.30

1.6

7.57

5.85

iu/ml

0.11

658

1479

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3186

7575

2.16

291.49

3.0

2.3

192.00

182.97

5.53

3039

7198

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2137

4245

2.57

288.78

1.7

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

1638

2807

2.97

288.22

1.6

1.5

30.27

34.85

ng/l

0.97

1632

2800

(3043409) Potassium [Moles/volume] in Arterial blood

2591

5746

2.30

278.46

4.8

4.2

3.85

3.89

mmol/l

3.28

2565

5706

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2002

3932

2.59

276.39

1.3

1.2

168.21

120.51

titre

0.30

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

3192

7772

2.11

275.01

1.3

1.2

41.78

37.57

u/ml

0.30

177

404

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

775

772

5.07

272.98

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2137

4372

2.49

272.27

1.6

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1981

3901

2.59

272.08

1.3

1.2

310.99

304.39

titre

0.04

131

279

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1244

1854

3.40

271.13

1.7

1.3

1.21

1.42

promille

3.57

949

1513

(3047181) Lactate [Moles/volume] in Blood

2915

6894

2.16

269.74

6.2

5.2

1.35

1.29

mmol/l

1.92

2611

6057

(3022806) Fractional oxyhemoglobin in Capillary blood

1363

2175

3.18

268.49

1.9

1.6

90.18

90.23

0.10

1344

2140

(3007566) Smooth muscle Ab [Titer] in Serum

3065

7464

2.10

263.74

1.3

1.2

97.69

124.11

titre

1.28

316

723

(1175426) CD3 cells/Lymphocytes in Blood

1061

1462

3.67

257.59

2.3

1.9

74.03

72.38

2.22

1017

1410

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1644

3016

2.77

257.26

1.8

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

2684

6256

2.19

256.97

3.5

2.8

2.33

2.20

index

0.27

1534

2938

(3022145) Colonoscopy Study observation

9331

31900

1.53

256.74

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

3104

7685

2.07

255.90

4.7

3.0

1.55

1.39

mg/l

18.13

2904

7041

(3034770) Mitochondria Ab [Titer] in Serum

2987

7292

2.10

255.27

1.3

1.2

854.08

989.41

titre

0.46

204

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

1027

1391

3.74

255.04

2.3

1.9

14.02

15.24

2.56

996

1357

(3020682) Albumin/Creatinine [Ratio] in Urine

22132

88832

1.36

254.96

4.6

4.1

11.90

6.97

mg/mmol

28.64

14456

55061

(3019230) Fractional oxyhemoglobin in Venous blood

2207

4733

2.38

254.86

4.3

2.6

62.14

63.80

2.44

2198

4721

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1794

3470

2.63

254.81

1.4

10.36

17.50

u/ml

1.17

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

55359

254387

1.38

252.55

27.6

14.1

13.69

13.45

306.98

54944

250540

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2624

6135

2.18

249.28

1.3

1.2

10.42

20.68

u/ml

0.82

(3045142) Bone marrow Pathology biopsy report

1225

1916

3.24

248.69

1.5

1.2

—

(3045424) Erythrocytes [Presence] in Urine

4393

12422

1.82

247.39

2.4

1.9

0.03

0.10

estimate

0.54

1347

4268

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2964

7309

2.07

246.73

1.3

5.59

5.82

u/ml

0.05

278

657

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2957

7297

2.07

245.67

1.3

9.22

8.07

u/ml

0.32

420

1015

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

942

1238

3.85

243.17

1.5

1.3

—

(3012516) Albumin [Mass/volume] in Urine

21721

87476

1.35

241.57

3.9

3.5

63.39

42.68

mg/l

19.53

14538

55138

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1304

2175

3.04

239.55

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

970

1327

3.70

237.72

2.8

2.5

215.38

245.52

e6/l

2.65

810

1108

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

6553

20973

1.62

237.21

3.1

2.4

68.11

70.85

ml/min/173m2

4.82

2869

8285

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1643

3162

2.64

235.45

1.3

0.25

0.27

nmol/l

0.08

185

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

860

1085

4.00

233.57

2.6

1059.69

762.67

u/ml

2.01

849

1076

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

925

1243

3.76

232.05

1.7

1.5

—

(40761536) Microorganisms panel - Urine sediment

6812

22138

1.60

231.44

4.7

3.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1613

3118

2.63

229.20

1.3

1.27

1.76

nmol/l

0.21

1568

3012

(4062490) Immunoglobulin typing, IgG

1329

2305

2.92

228.97

1.5

1.3

—

(36660697) Celiac disease serology panel - Serum

7269

24063

1.57

228.38

1.2

—

(3037121) Protein [Mass/volume] in Urine

3115

8054

1.98

228.19

3.7

3.3

472.11

492.78

mg/l

0.10

1591

3622

(21494815) CD4 cells/Lymphocytes in Specimen

1128

1778

3.21

226.28

2.4

2.1

39.07

39.63

0.48

1101

1751

(3008295) Osmolality of Serum or Plasma

1240

2082

3.02

225.33

1.5

279.39

281.06

mosm/kgh2o

1.24

946

1605

(3028192) IgG subclass 2 [Mass/volume] in Serum

1338

2353

2.88

225.18

1.5

1.3

2.85

3.07

g/l

3.67

975

1670

(3027135) IgG subclass 1 [Mass/volume] in Serum

1338

2354

2.88

225.02

1.5

1.3

6.73

g/l

0.02

974

1672

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

932

1290

3.65

224.89

2.7

2.3

532.96

514.01

e6/l

0.41

736

1026

(3024139) IgG subclass 3 [Mass/volume] in Serum

1337

2352

2.88

224.89

1.5

1.3

0.39

0.41

g/l

0.57

969

1673

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2500

5994

2.13

223.03

1.3

1.2

3.61

5.91

u/ml

0.74

164

388

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4696

14041

1.72

218.48

2.6

2.3

6301.86

6179.25

u/l

0.08

1712

5863

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1155

1897

3.08

217.39

1.2

1.1

39.82

45.58

mg/l

2.04

982

1617

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

738

885

4.21

212.97

1.3

67.30

66.13

0.09

106

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

731

870

4.24

212.81

1.5

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1990

4436

2.28

210.71

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2362

5663

2.13

210.57

2.4

2.1

130.02

132.61

g/l

4.59

1891

4317

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1117

1836

3.08

209.97

1.1

259.51

265.45

mg/l

0.20

993

1646

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

2411

5883

2.09

205.58

1.3

1.2

41.99

47.51

u/ml

0.68

230

495

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1032

1636

3.19

205.20

1.3

1.2

80.84

79.66

0.15

105

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1960

4394

2.27

204.84

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

532

485

5.53

203.94

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

1190

2076

2.90

202.95

3.7

3.0

57.80

56.08

1.58

1046

1748

(3007461) Platelets [#/volume] in Blood

68452

330098

1.66

202.43

35.1

17.7

253.42

254.06

e9/l

1.58

67673

322739

(3011288) Drugs identified in Urine by Screen method Nominal

3755

10758

1.79

201.45

4.1

2.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1062

1748

3.07

199.18

1.1

—

(3035941) MCH [Entitic mass]

68458

330265

1.66

198.92

35.0

17.6

30.27

30.24

3.59

68086

326718

(3024731) MCV [Entitic mean volume] in Red Blood Cells

68458

330269

1.66

198.81

35.0

17.6

90.91

90.62

48.26

68086

326714

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

68461

330288

1.66

198.79

35.8

18.0

40.23

41.44

14.90

68065

326574

(3026361) Erythrocytes [#/volume] in Blood

68461

330313

1.66

198.12

35.1

17.6

4.45

4.56

e12/l

307.65

67559

321886

(3010813) Leukocytes [#/volume] in Blood

68470

330374

1.66

197.95

35.2

17.7

6.91

6.66

e9/l

66.21

67575

321924

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

927

1405

3.33

197.08

1.8

3.88

3.62

mg/l

0.77

885

1346

(3000963) Hemoglobin [Mass/volume] in Blood

68469

330406

1.65

196.93

35.4

17.8

133.72

137.10

g/l

307.65

68102

326900

(3026250) Tacrolimus [Mass/volume] in Blood

700

870

4.06

193.63

43.3

40.1

7.43

7.31

ug/l

0.58

636

797

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1381

2692

2.60

192.97

1.3

0.20

nmol/l

0.02

1054

2115

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

675

824

4.13

190.77

2.2

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

675

824

4.13

190.77

2.2

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

675

824

4.13

190.77

2.2

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

675

824

4.13

190.77

2.2

1.4

—

(3010503) CD19 cells [#/volume] in Blood

779

1075

3.66

188.73

2.8

2.4

300.55

295.14

e6/l

0.02

756

1046

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1467

2984

2.49

188.57

2.4

2.5

26.38

28.64

iu/ml

0.24

149

234

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1169

2114

2.80

187.39

1.3

1.2

25.27

4.87

u/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

3049

8368

1.86

187.06

3.8

3.5

1714.19

2195.23

u/ml

0.16

2644

7253

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2732

7273

1.92

183.49

1.2

1.1

4.40

3.92

1.31

309

1283

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1405

2838

2.51

183.12

1.6

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1378

2770

2.52

181.34

1.6

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1377

2784

2.51

179.13

1.6

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2745

7418

1.89

176.27

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

640

800

4.03

175.83

1.1

1.00

0.12

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

887

1416

3.16

174.48

1.3

1.2

0.64

0.69

ratio

0.28

520

812

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

857

1345

3.22

173.02

2.8

2.4

0.68

0.71

e9/l

0.60

818

1300

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

845

1317

3.24

172.38

1.3

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

4584

14508

1.62

170.85

1.1

8.76

10.27

u/ml

0.09

167

(3010375) cycloSPORINE [Mass/volume] in Blood

616

767

4.05

170.05

31.5

26.5

115.51

120.76

ug/l

0.69

499

626

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

737

1055

3.52

169.93

1.5

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

692

947

3.68

169.54

2.5

1.8

127.22

144.68

umol/l

0.59

349

474

(3042631) Mycobacterium sp identified in Specimen

1295

2610

2.51

169.49

2.6

—

(4198724) Urine methamphetamine measurement

780

1165

3.38

169.40

3.3

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1084

2000

2.74

167.66

4.2

3.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2443

6454

1.93

167.53

1.5

1.3

—

(3000012) Reticulocyte production index

1362

2841

2.43

166.23

2.3

2.0

0.94

0.91

1.04

964

1779

(3045716) Anion gap in Serum or Plasma by calculation

1133

2159

2.65

165.18

3.4

3.0

10.73

10.95

mmol/l

0.88

1114

2134

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1298

2656

2.47

164.78

1.6

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

6343

21816

1.50

164.27

1.3

1.2

119.05

150.68

u/ml

8.19

2336

8482

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

704

1000

3.55

164.06

1.6

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

2085

5253

2.02

163.08

3.8

2.5

1.52

1.58

mmol/l

1.99

2033

5133

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1299

2673

2.46

163.03

1.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1297

2669

2.46

162.76

1.6

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1757

4144

2.15

162.67

1.1

6.63

0.69

0.70

(3009214) Lutropin [Units/volume] in Serum or Plasma

3371

9955

1.73

162.35

1.5

1.4

9.83

9.20

u/l

1.70

2709

8024

(3014765) Yersinia sp identified in Stool by Organism specific culture

2580

7026

1.87

161.66

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

677

945

3.61

161.56

1.6

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2565

6984

1.87

160.79

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

2582

7049

1.86

160.55

1.2

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1527

3422

2.26

159.45

1.2

15.95

15.79

u/ml

0.01

131

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3480

10433

1.70

158.81

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

525

609

4.34

157.48

2.1

1.5

8913.44

16447.10

u/ml

0.34

(3020961) Endomysium IgA Ab [Titer] in Serum

4477

14412

1.59

155.21

1.1

161.75

194.77

titre

0.43

471

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3052

8872

1.75

155.02

1.4

1.3

—

152.95

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

786

1270

3.12

151.78

1.1

1.15

1.09

u/l

0.50

325

509

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

735

1139

3.25

151.26

2.9

2.7

40.12

40.38

0.11

418

569

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8174

30015

1.41

149.69

8.5

5.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

635

898

3.56

148.91

1.1

3.87

4.14

iu/ml

0.18

(3008898) HLA-B27 [Presence]

3535

10827

1.67

148.91

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

3971

12560

1.62

147.65

1.7

1.6

312.37

295.81

mu/l

1.64

3586

11396

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

6064

21143

1.48

145.96

1.5

—

(3039000) Anion gap in Blood by calculation

1880

4780

2.00

143.30

7.8

6.1

11.33

11.32

mmol/l

0.05

1710

4286

(3018572) Chloride [Moles/volume] in Blood

1880

4781

1.99

143.22

7.9

6.1

104.99

105.29

mmol/l

1.71

1710

4288

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

547

712

3.87

143.02

1.3

1.2

0.30

g/l

0.14

442

563

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10763

41636

1.35

142.75

2.3

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

492

593

4.18

141.26

2.5

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1721

4260

2.05

140.90

1.3

1.2

3.86

3.92

u/ml

0.06

819

2021

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

486

584

4.19

140.03

2.5

1.5

—

(3016038) Potassium [Moles/volume] in Urine

736

1202

3.09

139.78

1.3

33.45

35.46

mmol/l

1.22

638

1077

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

486

585

4.18

139.75

2.5

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

714

1149

3.13

138.77

1.5

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

514

655

3.95

138.01

1.3

1.1

108.76

111.25

0.95

467

591

(3010838) Calcium [Moles/time] in 24 hour Urine

1746

4391

2.02

137.04

2.0

1.9

4.97

5.35

mmol/24h

4.18

1590

3969

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

554

755

3.69

136.55

2.3

1.9

30.40

28.06

2.66

523

723

(3023419) Bacteria identified in Sputum by Culture

1233

2697

2.31

135.88

2.8

2.5

—

(3011648) Oxygen content in Venous blood

1121

2347

2.41

135.71

3.2

2.3

10.89

11.35

2.46

1116

2338

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

971

1895

2.59

135.31

1.3

1.2

214.43

189.26

titre

0.32

158

285

(3011985) Renin [Units/volume] in Plasma

1513

3621

2.12

134.99

1.6

61.33

66.62

mu/l

0.35

1345

3312

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11547

45482

1.32

134.57

2.4

2.2

—

(3006245) CD3-CD19+ cells/cells in Blood

576

817

3.55

134.57

2.5

2.1

9.83

9.86

0.02

536

771

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

477

584

4.11

134.46

2.9

3.0

28.61

28.63

umol/l

0.01

354

459

(3003694) ABO and Rh group [Type] in Blood

21484

91552

1.25

134.39

1.6

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

968

1893

2.58

134.37

1.3

1.2

194.19

178.10

titre

0.08

(3040151) Glucose [Moles/volume] in Capillary blood

1183

2558

2.34

133.70

7.2

7.45

7.29

mmol/l

0.38

1016

2048

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

698

1135

3.10

133.49

1.5

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

3077

9350

1.68

133.16

2.1

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2688

7886

1.73

131.92

1.3

—

(4024509) Urine culture

3626

11527

1.61

131.67

2.1

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1736

4421

1.99

131.67

1.3

1.2

3.65

3.27

u/ml

0.37

671

1666

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1790

4612

1.97

131.46

3.9

3.4

656.37

1175.74

u/ml

1.03

1629

4154

(3020876) Protein [Mass/time] in 24 hour Urine

1212

2677

2.29

130.70

2.5

2.4

1.31

1.32

g/24h

0.04

753

1555

(21494890) Protein electrophoresis panel - 24 hour Urine

992

1994

2.51

130.50

2.2

1.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1012

2061

2.48

129.68

2.1

2.4

19.81

19.25

nmol/l

0.86

955

1977

(3042733) HLA Ab [Presence] in Serum

507

672

3.80

129.59

4.8

5.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1357

3164

2.17

129.05

1.2

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

362

357

5.10

128.97

1.8

1.9

44.91

30.40

u/l

0.64

330

318

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

737

1269

2.93

128.50

1.1

3.06

8.46

nmol/l

2.18

121

234

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

932

1831

2.57

128.24

3.3

2.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

2176

6051

1.83

127.43

1.7

1.6

14141.78

12799.21

e6/l

0.53

1557

4289

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1227

2759

2.25

127.06

2.3

2.1

32.51

32.60

0.25

1221

2736

(3024471) HLA-A [Type]

474

607

3.93

126.54

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3433

10871

1.61

126.52

1.6

1.7

16.60

15.14

u/ml

0.46

755

2970

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

561

819

3.45

125.95

1.1

303.04

471.81

ng/l

0.34

158

223

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

857

1627

2.66

125.83

22.8

20.6

2515.45

2325.34

nmol/l

0.05

827

1569

(3022621) pH of Urine by Test strip

6251

22556

1.42

124.64

2.8

2.3

6.10

6.09

0.30

4206

14361

(3016228) CD19 cells/cells in Blood

509

698

3.67

124.48

2.2

1.9

8.07

8.87

0.59

497

681

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

717

1243

2.91

123.61

1.5

1.4

5.78

5.80

u/l

0.02

624

1066

(3024932) HLA-DR beta [Type]

463

593

3.93

123.60

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

712

1234

2.91

122.81

1.8

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1392

3350

2.10

122.44

1.4

507.81

322.61

pmol/l

1.07

1188

2897

(3014148) Varicella zoster virus Ab [Titer] in Serum

1610

4103

1.99

121.83

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1405

3404

2.09

121.50

3.2

2.9

238.69

879.11

u/ml

1.10

1390

3369

(3000093) Morphology [Interpretation] in Blood Narrative

991

2068

2.42

120.81

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

287

236

6.11

120.63

1.5

1.2

269460.00

2110.53

u/ml

0.51

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

814

1538

2.67

120.59

17.0

15.5

811.59

2301.05

nmol/l

0.80

786

1492

(21494814) CD8 cells/Lymphocytes in Specimen

515

731

3.55

120.25

2.3

1.9

32.53

29.28

3.73

515

731

(3039162) Centromere protein B Ab [Units/volume] in Serum

1340

3201

2.12

120.07

1.3

1.2

51.41

56.75

u/ml

0.24

183

(3004616) Nuclear Ab [Presence] in Serum

1305

3086

2.14

119.90

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

5583

19873

1.44

119.57

1.3

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

776

1440

2.72

118.82

2.6

1.9

96.56

99.41

1.12

735

1333

(3006922) Hepatitis E virus Ab [Presence] in Serum

972

2029

2.42

118.42

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1115

2481

2.27

118.25

3.3

3.6

7.24

9.67

nmol/l

0.32

1075

2406

(3029634) Reagin Ab [Titer] in Serum by VDRL

1626

4206

1.96

118.04

2.2

2.3

9.08

8.29

titre

0.07

129

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

370

407

4.57

117.84

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

366

399

4.61

117.70

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

531

783

3.41

117.58

1.6

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

531

784

3.41

117.36

1.6

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

767

1424

2.72

117.35

3.0

3.9

143.14

156.97

nmol/l

0.23

752

1403

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1088

2407

2.28

116.90

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

439

564

3.92

116.77

1.2

1.3

23.91

20.41

0.33

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

370

412

4.51

116.29

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

962

2017

2.41

116.13

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2268

6572

1.75

115.94

1.5

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1571

4062

1.96

114.16

1.1

117.84

116.81

0.54

1434

3694

(3024666) Lithium [Moles/volume] in Serum or Plasma

797

1536

2.62

113.80

14.0

12.9

0.61

0.62

mmol/l

0.21

743

1416

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1095

2466

2.24

112.99

1.2

47.89

45.61

u/ml

0.08

109

(3002256) Pathology report gross observation

9684

38057

1.32

112.42

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1114

2534

2.22

112.32

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2126

6104

1.77

112.08

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

1674

4455

1.90

111.96

4.1

2.5

7.38

7.64

mmol/l

2.51

1632

4367

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1474

3751

1.99

111.94

1.1

1.52

1.48

g/l

3.00

1353

3433

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

413

526

3.95

111.07

2.2

1.7

1.69

1.88

ratio

1.11

399

508

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

58371

278333

1.25

111.05

4.5

3.9

1.33

1.27

mmol/l

62.39

54611

260342

(3000330) Specific gravity of Urine by Test strip

3786

12654

1.53

110.26

4.0

2.7

1.02

ratio

2.80

3430

11231

(4195642) Thrombophilia screening test

1549

4045

1.94

109.44

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

420

556

3.80

107.61

1.5

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

981

2166

2.29

105.89

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

555

908

3.08

105.22

2.3

2.1

31.52

40.59

umol/l

0.39

(40765096) Chromosome analysis panel by Banding

356

420

4.26

104.92

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

702

1321

2.68

104.83

1.7

1.5

2444906.32

1525426.11

iu/ml

0.81

(40759836) Histone Ab [Presence] in Serum by Immunoblot

961

2114

2.29

104.59

1.2

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

887

1882

2.38

104.45

2.8

2.6

1149.09

1117.88

0.15

877

1863

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1597

4283

1.89

104.37

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1192

2886

2.09

103.25

1.2

1.1

1.88

1.81

iu/ml

0.04

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1044

2396

2.20

103.10

1.2

63.28

65.69

u/l

0.31

925

2099

(3044927) Protein electrophoresis panel - Urine

849

1779

2.41

102.65

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

610

1074

2.86

102.52

2.0

1.8

1.91

1.97

umol/l

0.83

565

971

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

949

2098

2.28

102.15

1.2

1.1

—

(4268621) Lupus anticoagulant assay

1238

3057

2.05

101.91

2.4

2.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

947

2094

2.28

101.89

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

443

638

3.49

101.47

2.3

1.9

0.20

1.14

e9/l

1.12

210

285

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

62037

298630

1.28

101.24

5.9

5.2

2.68

2.78

mmol/l

139.05

58503

281638

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

335

390

4.32

100.27

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

352

433

4.09

98.82

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

916

2025

2.28

98.62

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4910

17676

1.42

98.02

1.5

1.3

24.27

25.75

iu/l

2.33

4127

15173

(3019420) Tryptase [Mass/volume] in Serum or Plasma

719

1421

2.55

97.87

1.5

7.24

8.23

ug/l

0.64

653

1301

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

912

2028

2.27

96.90

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

820

1738

2.38

96.80

1.3

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

620

1142

2.73

96.31

1.2

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1098

2646

2.09

96.25

1.3

1.2

29.17

29.51

nmol/l

0.02

(21494434) Karyotype in Bone marrow

813

1722

2.38

96.11

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1367

3586

1.93

95.30

1.8

1.9

2509.80

4087.80

titre

0.79

164

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

809

1718

2.37

95.12

1.3

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

888

1968

2.27

95.08

1.2

1.1

—

(3021788) Differential panel - Synovial fluid

1653

4621

1.81

95.00

1.6

1.5

1.00

—

(3003434) Protein [Mass/volume] in Pleural fluid

1140

2812

2.05

94.11

1.5

1.4

32.25

44.75

g/l

0.62

1041

2567

(3042517) Benzodiazepines panel - Urine

266

267

5.00

93.28

3.4

2.5

—

(3035285) Chloride [Moles/volume] in Venous blood

974

2271

2.16

92.65

2.7

1.9

105.73

105.58

mmol/l

0.37

966

2251

(3041354) Potassium [Moles/volume] in Venous blood

974

2272

2.16

92.55

2.7

1.9

4.05

4.04

mmol/l

0.05

966

2252

(3051651) Icteric interference index of Serum or Plasma

620

1176

2.65

91.30

4.0

3.5

0.84

0.92

index

0.74

610

1136

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

292

329

4.46

90.72

1.3

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

913

2091

2.20

90.64

1.3

1.2

77.20

61.67

u/ml

0.60

(3033705) Calcium.ionized [Moles/volume] in Venous blood

954

2237

2.15

89.52

2.7

2.0

1.20

mmol/l

1.01

946

2217

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

794

1724

2.32

89.00

1.2

1.1

1.23

1.09

0.30

(3004716) Salmonella sp identified in Stool by Organism specific culture

4255

15199

1.43

88.33

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

329

423

3.91

87.58

1.2

255.56

702.22

titre

0.58

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

523

926

2.84

87.14

2.6

2.5

146.15

152.95

nmol/l

0.59

464

820

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

447

719

3.13

87.13

3.0

2.7

0.61

0.62

mmol/l

0.98

447

719

(40768443) Skin Pathology biopsy report

3586

12442

1.47

86.71

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1379

3749

1.86

86.47

3.3

3.1

0.82

0.79

nmol/l

1.32

1063

3009

(40768446) Kidney Pathology biopsy report

515

914

2.83

85.47

1.9

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

516

917

2.83

85.44

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

516

917

2.83

85.44

1.5

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

61236

295425

1.24

84.81

5.3

4.7

4.56

4.69

mmol/l

191.08

57949

279764

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1447

4020

1.82

84.81

1.1

2.61

2.82

0.31

202

814

(21491868) Cryoglobulin [Mass/volume] in Serum

452

746

3.05

84.63

1.3

1.2

0.21

0.42

g/l

0.59

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2490

8030

1.57

84.48

1.9

2.1

12.05

15.94

iu/l

0.20

1011

3422

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6939

27000

1.32

84.45

2.6

2.2

12.32

13.20

nmol/l

14.11

6256

24822

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

867

2002

2.18

84.44

4.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1626

4687

1.75

84.44

1.4

1.3

25.41

24.75

u/l

0.31

1337

3833

(3003129) Base excess in Capillary blood by calculation

1087

2746

2.00

84.23

2.6

1.9

0.57

0.37

mmol/l

0.82

1028

2629

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1185

3102

1.93

83.13

1.2

1.1

97.05

97.04

0.01

1121

2906

(3008536) Aspergillus sp Ab [Presence] in Serum

276

321

4.32

82.81

2.5

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

693

1461

2.39

82.81

1.5

1.4

13.20

12.39

u/l

1.46

666

1417

(3020717) Zinc [Moles/volume] in Serum or Plasma

676

1410

2.41

82.61

1.6

1.5

22.12

23.31

umol/l

0.42

631

1306

(3038026) Centromere Ab [Units/volume] in Serum

788

1766

2.25

82.31

1.2

51.00

51.47

u/ml

0.01

110

(3028433) Virus identified in Specimen by Culture

383

578

3.33

82.20

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7031

27516

1.31

81.94

2.3

2.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1011

2513

2.03

81.83

1.5

1.4

2640.02

3233.03

e6/l

0.42

711

1753

(3017315) Amylase [Enzymatic activity/volume] in Urine

601

1190

2.54

81.60

1.4

1.2

293.05

362.43

u/l

0.69

558

1113

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

797

1802

2.23

81.58

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

457

779

2.95

81.22

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

486

860

2.84

81.10

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

368

547

3.38

80.74

3.4

3.0

1.79

1.96

ratio

0.95

340

494

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

6672

42303

0.77

80.23

1.9

3.52

3.50

ratio

0.59

5047

31909

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4543

16692

1.39

80.03

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

194

166

5.86

79.00

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

599

1207

2.50

78.58

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1057

2712

1.97

78.49

2.1

2.0

25.55

26.91

ug/l

0.25

1034

2668

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

60855

293862

1.23

78.29

5.2

4.6

1.42

1.46

mmol/l

131.45

57348

276874

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

468

830

2.84

77.82

3.6

3.0

1.39

1.16

1.65

468

830

(21494755) Public health laboratory ask at order entry panel

5784

37233

0.76

77.82

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

532

1017

2.63

77.30

2.1

1.7

27.64

29.18

umol/l

2.43

506

949

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

218

217

5.04

77.18

1.6

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

4053

14695

1.40

77.07

3.9

3.1

61.81

46.75

u/ml

1.07

3916

14239

(3044242) Glucose [Moles/volume] in Arterial blood

551

1076

2.58

76.88

2.1

1.9

8.00

8.11

mmol/l

0.24

551

1076

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1697

5089

1.69

76.65

1.1

18.59

14.79

au/ml

1.08

400

1541

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

603

1235

2.46

76.56

1.7

1.9

153.08

140.40

2.68

571

1174

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

4886

32024

0.75

74.63

1.6

3.44

3.48

mmol/l

2.07

3297

21498

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

264

324

4.09

74.47

6.5

6.0

2145.43

12175.17

iu/ml

0.67

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1444

4183

1.74

73.73

1.3

38.49

26.03

u/l

2.47

1274

3624

(40768441) Liver Pathology biopsy report

770

1796

2.16

73.26

1.6

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5921

22960

1.32

73.22

2.2

2.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1396

4018

1.75

72.86

1.4

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

676

1495

2.28

72.84

1.1

1552.49

1497.36

miu/ml

0.56

676

1495

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

860

2114

2.05

71.72

1.5

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

54411

260538

1.18

71.53

29.0

14.7

332.50

332.99

g/l

28.26

54145

258947

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

857

2109

2.05

71.27

1.1

288.74

425.24

mg/l

0.49

788

1924

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

796

1909

2.10

70.73

1.7

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

183

167

5.50

70.42

3.4

3.2

41.39

41.88

umol/l

0.08

162

139

(3028308) Erythrocytes [#/volume] in Pleural fluid

891

2238

2.01

70.18

1.5

1.4

50136.23

48018.98

e6/l

0.06

509

1253

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

579

1215

2.40

69.96

1.7

1.6

4.51

9.12

nmol/l

0.47

476

1015

(3051611) Lipemic interference index of Serum or Plasma

884

2219

2.01

69.75

3.9

3.1

14.33

13.52

index

0.93

612

1137

(3016244) Insulin [Units/volume] in Serum or Plasma

753

1779

2.13

69.47

3.3

3.2

24.76

27.14

mu/l

0.96

711

1677

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1321

3798

1.76

69.21

1.7

359.73

376.82

mu/l

0.56

1090

3080

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1753

5448

1.63

69.12

3.0

1.9

0.91

0.84

nmol/l

3.38

1476

4669

(3017569) Oxygen content in Arterial blood

536

1091

2.47

68.97

2.2

15.96

16.23

0.89

536

1091

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

628

1379

2.29

68.78

1.3

1.2

100.12

83.79

u/l

2.25

547

1174

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

770

1846

2.10

68.50

1.4

12.52

11.84

umol/l

1.63

726

1747

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

807

1971

2.06

68.46

2.8

1.8

—

(3004451) EKG impression Narrative

528

1080

2.46

67.29

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

610

1344

2.28

66.33

1.3

1.2

27.09

21.26

u/l

1.56

524

1121

(3002079) Sodium [Moles/time] in 24 hour Urine

553

1169

2.38

65.82

1.3

155.75

166.55

mmol/24h

1.73

553

1169

(3019832) Treponema pallidum Ab [Presence] in Serum

9677

40348

1.23

65.65

1.9

1.8

—

(40768806) Pleura Pathology biopsy report

846

2143

1.99

65.16

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

586

1282

2.30

64.75

1.2

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

487

981

2.50

64.04

6.4

3.6

1412.48

3521.29

mg/l

1.20

374

673

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

783

1940

2.03

64.01

1.3

380.64

517.78

u/l

1.74

734

1848

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

587

1294

2.28

63.78

1.6

1.5

6.67

6.78

u/l

0.06

452

1041

(3020911) Cortisol [Moles/time] in 24 hour Urine

437

841

2.61

62.82

1.5

1.4

202.88

193.05

nmol/24h

0.04

437

841

(3045788) Cell count panel - Pleural fluid

807

2043

1.99

62.28

1.5

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

487

998

2.45

61.88

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

438

851

2.59

61.84

2.1

2.8

1.19

0.99

ug/l

1.02

410

806

(3047189) Immunofixation for 24 hour Urine

437

849

2.59

61.71

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

191

210

4.56

61.14

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

125

7.37

61.10

2.3

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

828

2132

1.96

60.98

1.3

6.35

6.20

mmol/l

0.74

771

1985

(3017704) Immunofixation for Urine

495

1031

2.41

60.83

1.7

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

442

872

2.55

60.60

2.6

2.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

1051

2938

1.80

60.46

1.6

1.5

58.24

54.55

1.94

678

1846

(3001964) Herpes simplex virus Ag [Presence] in Specimen

335

569

2.96

60.06

1.7

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2367

8135

1.47

59.69

1.1

5.30

5.58

eliau/ml

0.09

281

1171

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

178

190

4.70

58.82

10.5

6.8

0.35

umol/l

0.03

162

163

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

821

2138

1.93

58.57

1.2

108.69

114.92

pmol/l

2.33

821

2138

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

197

232

4.26

58.44

11.5

8.6

5.14

5.69

mmol/l

1.45

197

232

(3032352) Blasts [#/volume] in Cerebral spinal fluid

156

150

5.22

57.26

2.7

2.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

3173

11599

1.39

57.13

1.3

214.22

227.32

miu/ml

1.11

1307

5728

(3036603) Volume of Urine

735

1859

1.99

56.91

1.7

1.6

2103.35

2013.17

1.28

720

1816

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

524

1163

2.27

56.14

1.2

1.1

9.39

14.95

u/ml

0.44

119

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

19141

85819

1.16

55.95

5.1

3.17

2.81

ug/l

0.59

17369

78240

(3023487) Leukocytes [#/volume] in Peritoneal fluid

388

751

2.60

55.25

2.4

1.7

750.83

4402.36

e6/l

1.49

273

474

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

671

1663

2.03

54.89

1.2

1.1

1.07

1.06

ratio

0.29

558

1381

(3013247) Albumin in CSF/Albumin in Serum or Plasma

311

535

2.92

54.65

1.1

1.0

7.29

6.76

mg/g

0.28

295

513

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1695

5536

1.55

54.31

1.6

1.5

0.30

0.44

nmol/l

11.87

1289

4380

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

432

891

2.44

54.25

1.7

1.9

174.89

158.01

2.07

415

834

(3003329) Lymphocytes/Leukocytes in Synovial fluid

818

2189

1.88

53.93

1.6

1.5

30.84

33.41

1.06

507

1347

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

155

158

4.92

53.75

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

176

203

4.35

53.51

2.7

2.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

370

716

2.60

52.74

1.3

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

361

693

2.62

52.25

3.7

2.8

10.57

10.45

kpa

0.25

361

693

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

361

693

2.62

52.25

3.7

2.8

4.83

4.94

kpa

0.92

361

693

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

173

201

4.32

52.18

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

381

753

2.54

52.15

1.3

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

397

804

2.48

51.78

2.3

2.0

65.03

60.57

ug/l

0.42

389

790

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

438

934

2.36

51.32

3.9

4.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

786

2114

1.87

51.08

1.4

1.3

1.94

2.68

u/ml

0.98

470

1214

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

249

390

3.20

50.83

1.3

1.18

mmol/l

0.64

249

390

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

153

163

4.71

50.74

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

191

248

3.86

50.48

2.1

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

155

168

4.63

50.48

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

1710

5693

1.52

50.24

5.0

3.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

133

125

5.34

49.95

3.4

2.8

2.22

2.32

mg/l

0.18

116

106

(3028679) Herpes simplex virus Ab [Presence] in Serum

647

1644

1.98

49.54

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

908

2583

1.77

49.41

1.4

1.3

1.49

1.44

nmol/l

0.63

828

2328

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

788

2172

1.83

47.52

5.0

3.6

65.93

49.94

u/ml

0.71

782

2144

(3013727) Leukocytes other/Leukocytes in Blood

322

613

2.64

47.41

3.8

3.1

52.17

52.45

0.07

316

584

(3026692) Albumin [Mass/volume] in Peritoneal fluid

287

513

2.81

47.34

1.5

1.3

13.29

13.63

g/l

0.20

204

394

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

335

652

2.58

47.30

2.2

1.6

16131.54

11863.13

e6/l

0.26

183

312

(3012565) Volume of 24 hour Urine

491

1143

2.16

47.16

2.1

2.2

2008.27

2008.40

0.00

443

1032

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

158

186

4.26

47.01

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

403

869

2.33

46.16

1.2

109.11

109.60

0.07

372

778

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

389

826

2.37

46.06

1.2

1.1

91.05

93.26

0.41

195

370

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

533

1295

2.07

46.03

1.2

1.1

88.60

79.24

u/l

1.19

470

1166

(3010144) Erythrocytes [#/volume] in Synovial fluid

798

2237

1.79

45.61

1.4

115000.45

98434.03

e6/l

0.28

541

1449

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

528

1286

2.06

45.32

1.2

1.1

29.21

19.59

u/l

1.99

464

1157

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

392

845

2.33

44.95

1.1

90.32

92.54

0.59

194

370

(37208534) Antinuclear antibody arbitrary concentration in serum

387

830

2.34

44.87

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

613

1584

1.95

44.85

1.4

1.5

23.31

25.72

u/ml

0.46

108

293

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

140

157

4.47

44.01

3.4

2.8

1.30

1.24

mg/l

0.08

116

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2945

11090

1.34

43.86

2.0

1.8

39.99

40.81

nmol/l

0.91

2887

10889

(3036071) Salmonella sp Ab [Titer] in Serum

372

793

2.36

43.72

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

2069

14288

0.72

43.68

1.1

0.65

0.63

ratio

0.82

202

1661

(42529582) MDA5 Ab [Presence] in Serum by Line blot

304

590

2.59

43.21

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

304

590

2.59

43.21

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

304

590

2.59

43.21

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

304

590

2.59

43.21

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

217

349

3.12

42.64

1.9

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1443

4811

1.51

42.15

2.3

2.2

8.33

6.04

umol/l

1.94

1077

3510

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2235

8108

1.39

41.99

2.1

1.8

195.93

204.07

pmol/l

2.52

2132

7753

(3044007) Cell count panel - Peritoneal fluid

317

643

2.48

41.35

2.3

1.7

—

(3014271) Vancomycin [Susceptibility]

379

837

2.27

41.25

3.1

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1428

4789

1.50

40.59

1.1

159.15

3189.02

iu/ml

0.75

309

997

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

589

1560

1.90

40.20

1.3

15.71

13.84

u/l

0.32

542

1454

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

7.76

40.16

1.3

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

246

449

2.75

39.22

1.4

1.3

24.13

65.89

g/l

0.55

181

354

(3035880) pH of Pleural fluid

440

1059

2.09

39.03

1.3

7.40

0.05

303

745

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

227

397

2.87

38.99

5.1

4.8

62.28

51.02

u/l

0.48

222

388

(40757373) Influenza virus identified in Isolate

208

345

3.02

38.99

1.7

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

265

508

2.62

38.63

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

321

678

2.38

38.55

1.4

1.2

123.88

137.26

nmol/l

0.63

244

508

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

236

428

2.77

38.08

1.6

1.7

1.21

1.14

nmol/l

0.15

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

671

1889

1.79

37.93

1.4

1.2

4.98

5.50

umol/l

2.72

600

1682

(3001686) Cold agglutinin [Titer] in Serum or Plasma

200

330

3.04

37.82

1.2

1.3

94.13

414.13

titre

0.60

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

549

1450

1.90

37.82

1.0

280.78

364.02

ng/l

2.42

402

1076

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.46

37.72

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

550

1457

1.90

37.56

1.0

758.66

758.94

ng/l

0.00

388

1053

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

26925

125730

1.11

37.30

2.0

1.8

1.43

1.35

mmol/l

34.19

23015

107395

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

550

1461

1.89

37.26

1.0

36.12

42.50

ng/l

2.41

391

1071

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

208

357

2.92

36.90

1.1

49.51

22.91

iu/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.83

36.65

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1651

5821

1.43

36.45

2.6

2.4

148.40

94.47

ug/min

3.24

1004

3538

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

459

1154

2.00

36.36

1.1

97.47

96.48

0.24

370

905

(3008116) Ketones [Moles/volume] in Urine by Test strip

259

508

2.56

36.19

1.6

1.4

0.33

0.24

mmol/l

0.47

(3048879) Bone marrow aspiration report

253

491

2.59

36.08

2.3

1.7

2.00

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

219

3.50

35.74

1.1

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

352

803

2.20

35.65

2.2

1.8

39.82

40.97

g/l

2.34

352

803

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

362

839

2.17

35.31

1.4

14.71

14.56

pmol/l

0.11

306

717

(3033923) Metanephrine [Moles/time] in 24 hour Urine

208

368

2.84

35.09

1.1

0.69

0.82

umol/24h

0.36

100

192

(3024869) Neuronal Ab [Presence] in Serum

199

343

2.91

35.09

1.1

—

(4034850) Laboratory test

2233

8343

1.35

34.98

11.6

9.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

931

2934

1.60

34.87

2.2

1.9

25.07

27.25

mg/l

0.61

343

1123

(3007463) Buprenorphine [Presence] in Urine

5.24

34.83

7.8

7.5

—

(3005570) Glucose [Moles/volume] in Urine

801

2435

1.65

34.59

2.2

1.8

0.98

25.73

mmol/l

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

5.18

34.47

1.1

1.0

3.47

2.80

u/l

0.19

(3001186) Copper [Moles/volume] in Serum or Plasma

320

711

2.26

34.46

1.5

1.3

16.35

16.61

umol/l

0.41

278

612

(3034426) Prothrombin time (PT)

354

822

2.16

34.39

1.3

1.2

28.34

27.89

0.74

354

822

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

526

1421

1.86

33.94

1.3

450.77

606.14

titre

0.28

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1172

3926

1.50

33.57

4.5

3.4

40.81

35.01

u/ml

0.48

1136

3771

(40758292) HTLV I+II Ab panel - Serum

232

449

2.59

33.31

1.4

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

188

324

2.91

33.19

1.4

1.3

70.26

116.12

ng/l

0.86

126

198

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

512

1382

1.86

33.14

1.3

67.37

79.21

titre

0.24

101

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

218

410

2.67

33.03

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

447

1156

1.94

32.81

1.6

1.4

4.80

4.23

0.20

251

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

755

2298

1.65

32.49

2.1

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

263

549

2.40

32.49

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.55

32.47

5.1

6.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

540

1497

1.81

32.18

1.6

1.26

1.27

nmol/l

0.02

408

1158

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

252

518

2.44

32.14

1.3

1.2

12.10

12.38

pmol/l

0.04

100

189

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

138

199

3.48

31.97

1.2

1.1

1.66

1.92

iu/ml

0.85

104

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

343

811

2.12

31.93

1.2

1.1

5.73

5.74

u/ml

0.00

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

2369

15325

0.77

31.75

1.2

1.1

0.89

g/l

0.06

2359

15283

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

106

4.59

31.50

2.0

1.6

157.59

196.22

ug/g

0.97

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

124

167

3.72

31.49

1.7

1.6

1.59

1.48

mg/l

0.10

121

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

203

380

2.68

31.06

2.9

2.5

48.80

33.67

mg/l

0.65

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

444

1175

1.90

30.54

2.8

2.2

157.96

205.92

ug/l

0.12

428

1116

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

168

286

2.95

30.32

1.4

1.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

120

164

3.67

29.93

1.6

2.13

2.62

mg/l

0.32

126

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

120

164

3.67

29.93

1.6

0.85

0.71

mg/l

0.24

120

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

120

164

3.67

29.93

1.6

3.66

4.53

mg/l

0.53

112

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

120

164

3.67

29.93

1.6

2.53

2.37

mg/l

0.11

121

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

120

164

3.67

29.93

1.7

1.6

1.12

1.17

mg/l

0.04

114

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

120

164

3.67

29.93

1.7

1.6

2.32

1.72

mg/l

0.48

126

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

120

164

3.67

29.93

1.6

1.78

2.37

mg/l

0.42

113

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

12.53

29.90

4.6

4.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

688

2090

1.65

29.88

3.0

2.3

27.75

28.55

mg/l

0.20

512

1450

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

265

578

2.30

29.84

1.3

108.21

106.83

0.22

256

544

(3050794) Legionella sp Ab [Presence] in Serum

121

167

3.63

29.79

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

120

165

3.65

29.69

1.7

1.6

1.59

1.73

mg/l

0.10

112

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

120

165

3.65

29.69

1.7

1.6

1.55

1.96

mg/l

0.44

129

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

254

545

2.34

29.65

1.2

1.1

76.18

76.78

0.04

139

(40761539) Cells [Type] in Urine sediment by Light microscopy

237

493

2.41

29.55

1.3

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

253

545

2.33

29.29

1.2

1.1

85.07

87.76

0.23

147

(3002523) Influenza virus A Ag [Presence] in Specimen

1744

6447

1.36

29.27

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

244

517

2.37

29.27

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

138

212

3.26

29.25

1.4

1.1

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

147

236

3.12

29.16

1.4

1.3

52.32

53.99

0.12

121

(3003740) Influenza virus B Ag [Presence] in Specimen

1741

6441

1.36

29.08

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

177

319

2.78

29.03

5.7

5.1

40.99

43.36

ug/min

0.18

127

243

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

125

184

3.41

28.20

1.2

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

309

741

2.09

27.86

6.6

5.9

24.91

25.15

mmol/l

0.40

282

678

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7548

33056

1.16

27.56

4.8

4.6

31.98

32.09

0.32

5507

22537

(3005532) Lymphocytes/Leukocytes in Pleural fluid

286

669

2.15

27.43

1.4

60.92

64.00

0.67

232

566

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

166

299

2.78

27.29

2.2

2.0

—

(40762365) Oxygen content in Arterial blood by calculation

160

283

2.84

27.15

3.4

3.1

14.83

14.75

ml/dl

0.10

149

262

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

169

309

2.74

27.06

1.6

1.7

176435.70

331257.09

nmol/l

0.44

140

256

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

4.29

26.92

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1617

6005

1.36

26.40

1.8

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1410

5133

1.38

26.05

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

422

1161

1.82

25.90

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

164

303

2.71

25.80

1.2

61.98

63.85

ug/l

0.50

164

303

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.51

25.76

1.4

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

110

158

3.49

25.73

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.99

25.61

3.6

2.0

37837.31

96533.33

u/ml

—

(3036180) Methadone [Presence] in Urine

6.94

25.46

3.6

2.4

—

(3009871) Measles virus Ab [Titer] in Serum

404

1106

1.83

25.20

1.6

3304.30

3574.46

titre

0.27

161

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

303

752

2.02

25.06

1.8

1.6

129.14

27500205.67

iu/ml

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

784

2568

1.53

25.05

5.0

5.3

103.82

106.63

u/ml

0.04

270

873

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1243

4473

1.40

24.61

1.1

2.52

3.09

eliau/ml

1.10

541

2335

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.05

24.58

3.5

2.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.35

24.33

12.7

10.1

249.66

181.96

e6/l

0.21

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1242

4480

1.39

24.26

1.6

1.5

—

(3002619) Bacteria identified in Specimen by Culture

263

626

2.11

24.25

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1707

6478

1.33

24.17

1.5

1.4

132.04

121.80

pmol/l

0.41

1665

6314

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

180

362

2.49

24.16

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

150

274

2.74

24.13

1.6

115.33

110.28

ug/l

0.19

124

218

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

110

166

3.32

24.03

1.2

0.56

0.62

iu/ml

0.17

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

699

2258

1.56

23.78

1.1

19.19

18.83

u/ml

0.06

259

988

(3013862) HLA-DP [Type]

5.01

23.58

1.0

—

(3006270) Folate [Moles/volume] in Blood

619

1947

1.60

23.57

1.2

1.1

371.05

376.25

nmol/l

0.22

516

1713

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

941

3252

1.45

23.27

1.1

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

174

351

2.49

23.23

2.1

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

167

330

2.54

23.23

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

175

355

2.47

23.11

1.5

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

382

1057

1.81

23.09

2.6

2.8

153.73

127.01

au/ml

0.43

164

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

187

392

2.39

23.08

2.4

1.9

1.19

mmol/l

0.11

181

371

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

207

455

2.28

23.06

1.2

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

126

3.66

23.00

1.2

1.4

77.26

82.85

umol/l

0.61

113

(3010015) Selenium [Moles/volume] in Serum or Plasma

141

256

2.76

22.95

2.2

1.8

1.29

1.35

umol/l

0.79

115

174

(3018133) Calcium [Moles/volume] in Urine

216

486

2.23

22.83

1.8

2.1

2.62

2.81

mmol/l

0.66

195

448

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

166

330

2.52

22.83

2.8

2.0

0.84

1.57

mmol/l

3.84

109

237

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

14905

68815

1.11

22.78

4.3

4.2

21.89

22.08

0.71

6743

31930

(3021162) Amylase [Enzymatic activity/volume] in Specimen

175

358

2.45

22.73

2.6

3.0

1218.24

1808.83

u/l

0.43

158

326

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

128

221

2.90

22.72

1.3

1.2

—

(3033099) Centromere Ab [Titer] in Serum

259

631

2.06

22.55

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

488

1467

1.67

22.22

1.2

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

422

1221

1.73

22.04

3.5

3.6

8.73

mg/l

0.00

345

982

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

106

166

3.20

21.97

1.4

1.3

15.99

12.57

pmol/l

0.27

139

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

129

229

2.82

21.87

1.5

—

(40760409) HLA-A [Type] by High resolution

4.78

21.51

1.0

—

(40760410) HLA-B [Type] by High resolution

4.78

21.51

1.0

—

(40763590) HLA-DQ beta [Type]

4.78

21.51

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

180

385

2.34

21.34

2.4

1.9

1.18

1.19

mmol/l

0.52

171

366

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

114

3.69

21.29

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

135

250

2.71

21.26

1.3

236.75

140.60

titre

—

(46236302) HLA-C [Type] by High resolution typing

4.71

21.19

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

234

562

2.09

21.18

1.3

400.24

187.93

ug/l

0.63

113

318

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

153

304

2.52

21.11

3.1

2.7

22.13

24.67

mg/l

1.29

146

292

(37021550) Renin [Units/volume] in Plasma --upright

191

422

2.27

21.09

1.3

120.18

66.27

mu/l

0.74

144

326

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

107

174

3.08

20.96

1.2

0.09

0.47

u/ml

1.02

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

110

3.69

20.52

1.1

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

172

367

2.35

20.52

1.1

1.0

0.09

0.33

u/ml

1.07

105

230

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

230

557

2.07

20.40

1.6

0.40

ug/l

0.08

187

395

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

222

531

2.10

20.32

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

222

531

2.10

20.32

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

222

532

2.09

20.23

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

1964

7782

1.27

20.19

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

6.44

20.10

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

647

2139

1.52

19.95

3.1

2.9

56.70

49.87

mg/l

0.22

474

1520

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

148

299

2.48

19.79

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1972

7845

1.27

19.63

1.2

1.1

1.98

2.35

u/ml

0.79

1094

4165

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

158

3.11

19.49

2.4

3.7

71.43

436.38

pmol/l

0.45

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

204

480

2.13

19.48

1.3

1.2

379.54

302.06

pmol/l

0.45

147

373

(3001893) Eosinophils/Leukocytes in Pleural fluid

235

585

2.01

19.43

1.4

3.22

2.74

0.29

194

504

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

120

3.47

19.36

1.4

34.57

39.30

0.35

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.01

19.35

1.5

1.2

—

(3024263) Appearance of Synovial fluid

406

1208

1.69

19.29

1.9

1.7

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

378

1103

1.72

19.25

1.4

500.14

699.30

mu/l

1.01

358

1056

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

423

1275

1.67

19.16

1.2

1.3

1004.49

1082.33

titre

0.52

266

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

383

1124

1.71

19.12

1.4

73.62

72.83

0.53

363

1077

(3002621) Streptococcal DNAse B [Units/volume] in Serum

113

202

2.80

19.00

1.1

346.95

313.11

u/ml

0.17

(3010370) Gastrin [Moles/volume] in Serum or Plasma

169

371

2.28

18.99

1.9

46.51

43.17

pmol/l

0.14

145

316

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

114

205

2.79

18.97

1.1

22.19

21.53

u/l

0.09

126

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

349

1000

1.75

18.94

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

176

395

2.23

18.82

5.9

8.1

67.24

72.06

1.21

127

313

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

139

281

2.48

18.60

1.8

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

138

278

2.49

18.60

3.1

2.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

251

654

1.92

18.33

1.3

1.2

39.02

40.56

g/l

0.71

133

338

(3042951) Complement C1q Ab [Units/volume] in Serum

3.90

18.28

1.1

1.3

24.86

18.65

u/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

216

536

2.02

18.06

1.2

47.00

23.48

u/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

247

644

1.92

18.02

1.9

1.5

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

125

3.29

17.79

1.3

1.1

25.19

17.77

0.45

(3011544) Albumin [Mass/volume] in Pleural fluid

105

188

2.80

17.64

1.1

16.12

18.38

g/l

1.68

175

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

101

3.57

17.55

1.1

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

674

2310

1.47

17.54

1.1

8.60

7.66

iu/ml

0.44

159

679

(43055514) Macroprolactin [Presence] in Serum or Plasma

299

841

1.78

17.31

1.3

1.4

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

5.51

17.28

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

108

199

2.72

17.26

1.0

0.05

0.04

u/ml

0.18

108

199

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

100

3.56

17.22

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

200

492

2.04

17.14

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

3.79

17.10

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

150

3.01

17.06

1.9

1.7

53.08

41.17

umol/l

2.56

150

(4015189) Microbial culture of sputum

203

504

2.02

16.98

2.2

—

(44806071) Cardiolipin IgM antibody measurement

163

371

2.20

16.93

1.1

—

(3017509) Phencyclidine [Presence] in Urine

158

355

2.23

16.91

2.0

1.6

—

(44813793) Dust mix specific IgE antibody measurement

641

2194

1.47

16.82

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

154

343

2.25

16.82

1.3

96.99

71.27

mmol/24h

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

107

3.42

16.77

1.1

1.0

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

146

319

2.29

16.65

2.9

2.1

2.24

2.73

0.68

146

313

(3019174) dRVVT (LA screen)

110

209

2.64

16.65

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

124

252

2.47

16.48

1.1

40.00

38.74

titre

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

375

1143

1.65

16.38

2.2

2.0

8.45

9.37

mg/l

2.52

311

943

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

107

203

2.64

16.25

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

418

1313

1.60

16.21

1.9

1.7

2.51

2.59

u/field

0.07

301

952

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

100

3.46

16.12

1.5

520.64

523.23

nmol/l

0.01

100

(3044009) aPTT.lupus sensitive (LA screen)

110

213

2.59

16.09

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

124

3.15

15.94

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

171

2.78

15.87

2.6

2.1

482.36

362.38

umol/l

0.28

166

(3000919) Neutrophils/Leukocytes in Pleural fluid

207

532

1.95

15.80

1.4

25.71

19.64

1.99

185

490

(3045462) Protein/Creatinine [Ratio] in Urine

152

348

2.19

15.62

5.0

4.4

63.84

40.68

mg/mmol

0.71

138

318

(3013166) Neutrophils/Leukocytes in Synovial fluid

237

641

1.85

15.60

1.4

55.79

52.66

0.59

198

546

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.32

15.42

1.2

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

101

192

2.64

15.31

1.1

1.68

1.75

umol/24h

0.21

101

192

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

152

2.87

15.31

1.4

1.5

17.22

15.00

pmol/l

0.34

135

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.70

15.19

1.8

1.5

214.74

282.00

nmol/l

0.27

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

4.90

15.13

6.1

5.7

1.56

1.24

mg/l

0.30

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

578

1981

1.46

15.13

2.1

1.9

1.58

3.16

u/field

0.75

327

1118

(3051339) Copper [Moles/volume] in Blood

105

3.29

15.07

1.2

1.4

15.73

16.75

umol/l

1.10

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

464

1522

1.53

14.99

1.4

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

204

532

1.92

14.98

2.3

2.9

33.25

351.87

ug/l

1.23

204

532

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

169

412

2.06

14.91

2.3

2.7

—

(3020491) Glucose [Moles/volume] in Blood

584

2014

1.46

14.83

1.8

1.7

6.81

6.56

mmol/l

1.01

452

1494

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

155

2.81

14.83

1.9

2.2

62.10

58.96

0.27

100

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

3.79

14.81

1.1

0.04

0.67

mg/l

0.51

(3003888) Timothy IgE Ab [Units/volume] in Serum

1704

6917

1.24

14.34

1.1

4.81

5.61

u/ml

1.29

947

3723

(3045683) HLA typing for celiac disease panel - Blood or Tissue

549

1886

1.46

14.24

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

314

951

1.66

14.14

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1636

6622

1.24

14.14

1.1

0.99

1.12

u/ml

0.33

761

2952

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

128

2.94

13.77

2.7

2.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.68

13.75

1.2

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

4.06

13.54

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

109

230

2.38

13.51

1.1

—

(3024316) Viscosity of Plasma

3.27

13.46

1.7

1.9

1.48

1.83

mpas

1.86

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

111

3.07

13.42

1.5

1.4

15.71

11.16

0.62

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

5.15

13.35

5.1

6.8

5.32

7.90

mg/l

0.44

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

284

851

1.67

13.34

1.8

1.7

137.65

121.17

au/ml

0.18

119

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

224

629

1.79

13.19

8.0

6.6

5.97

5.99

kpa

0.11

200

571

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

432

1437

1.51

13.17

6.8

6.5

1348.59

3729.36

u/ml

0.45

269

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

169

2.61

13.16

1.3

1.18

1.77

ml/s/173m2

0.56

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

162

409

1.99

13.10

1.9

2.6

7.37

7.49

mmol/l

0.12

117

218

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

545

1902

1.44

13.08

2.2

1.9

837.96

790.27

pmol/l

0.02

265

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1512

9276

0.81

12.92

1.5

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

162

2.63

12.91

1.0

12.82

20.00

u/ml

0.82

130

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

247

719

1.72

12.90

1.6

9.40

9.12

ug/l

0.38

247

719

(3023383) Lactate [Moles/volume] in Pleural fluid

220

619

1.78

12.89

1.4

1.3

3.66

3.58

mmol/l

0.10

198

568

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

4.45

12.81

1.8

1.6

276.83

183.41

nmol/l

0.44

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

109

3.03

12.81

1.1

1.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

124

285

2.18

12.73

1.5

1.3

10.63

13.12

0.48

149

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.75

12.70

5.3

3.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

132

315

2.10

12.39

1.0

0.47

0.24

u/ml

0.36

192

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

624

2256

1.39

12.32

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1607

6601

1.22

12.17

1.1

1.55

2.03

u/ml

1.50

878

3319

(3011335) Digoxin [Mass/volume] in Serum or Plasma

121

2.86

12.17

2.1

0.65

0.67

ug/l

0.14

121

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1553

9441

0.82

12.13

1.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

102

3.05

12.13

1.5

1.2

1.11

0.78

umol/24h

0.25

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

174

2.51

12.08

1.0

1.1

23.51

28.41

u/ml

0.29

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

174

2.51

12.08

1.0

1.1

29.85

32.18

u/ml

0.09

(3005033) Fetal Nuchal fold Thickness US

1488

9080

0.82

12.08

1.5

1.24

1.26

0.49

1054

6676

(3026051) Granulocytes/Leukocytes in Pleural fluid

168

443

1.90

12.06

1.4

24.07

22.38

0.29

136

380

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.11

12.02

1.2

1.0

—

mmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1065

4183

1.28

11.96

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

212

2.34

11.95

1.3

1.2

6.08

6.26

mmol/l

0.09

(40758047) Lysozyme [Mass/volume] in Pleural fluid

180

2.45

11.70

1.1

9.48

10.05

mg/l

0.17

165

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.09

11.67

1.1

1.4

64.33

30.76

umol/24h

0.45

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

128

310

2.07

11.61

1.1

2.33

3.48

u/ml

0.29

246

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

187

518

1.81

11.58

1.5

5.56

5.84

nmol/l

0.39

178

495

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.15

11.57

1.1

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.90

11.57

1.1

0.20

0.22

g/l

0.77

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.48

11.46

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

122

292

2.09

11.41

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.51

11.35

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

101

2.98

11.34

1.2

1.1

1.14

u/field

0.01

(3012898) Urea [Moles/volume] in Urine

111

257

2.16

11.27

1.4

1.7

175.52

172.64

mmol/l

0.07

100

234

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

383

1286

1.49

11.26

1.1

8.55

10.32

u/ml

0.32

227

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

218

639

1.71

11.19

1.3

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

135

339

2.00

11.16

1.6

1.7

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

215

629

1.71

11.12

1.3

38.46

40.52

0.31

152

413

(3038071) Oxygen [Partial pressure] in Mixed venous blood

199

571

1.75

11.01

7.9

6.6

5.83

5.48

kpa

1.05

199

571

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

143

369

1.94

10.98

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.23

10.97

3.8

3.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

216

636

1.70

10.93

3.4

2.6

128.01

95.86

ng/l

0.93

137

333

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

811

3112

1.31

10.92

1.3

1.4

8.86

8.11

mmol/l

4.49

781

2978

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

143

372

1.93

10.74

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

193

2.31

10.52

1.0

3.68

1.55

u/ml

0.54

158

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

126

2.66

10.51

1.8

2.3

16.33

17.77

0.12

(3012494) Peanut IgE Ab [Units/volume] in Serum

276

876

1.58

10.48

1.1

2.59

10.85

u/ml

1.15

149

527

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.53

10.48

1.1

1.0

214.04

265.75

pmol/l

0.28

(3011841) English Walnut IgE Ab [Units/volume] in Serum

127

321

1.98

10.35

1.0

1.1

3.71

4.79

u/ml

0.19

251

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

107

2.81

10.35

3.5

3.3

—

(3004775) Volume in Urine collected for unspecified duration

520

1881

1.39

10.34

2.6

2.3

719.92

658.14

2.37

370

1330

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.27

10.30

1.0

0.05

0.15

u/ml

0.43

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

460

1630

1.42

10.29

7.3

7.2

94.66

61.33

ug/l

0.30

325

1067

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

122

2.67

10.25

6.6

4.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

177

2.35

10.19

1.3

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.29

10.18

1.0

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

3.92

10.03

1.6

1.7

1066.00

2044.40

umol/l

—

(3000285) Sodium [Moles/volume] in Blood

151

410

1.85

10.03

1.2

138.18

138.72

mmol/l

0.69

121

358

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

2.86

9.99

1.4

1.2

1.31

0.82

0.50

(3046861) Legionella sp Ag [Presence] in Urine

124

2.63

9.96

1.0

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

4.44

9.95

1.2

1.1

50.04

72.60

mu/l

0.21

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.91

9.89

1.0

0.13

0.10

u/ml

0.13

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.05

9.87

1.4

1.2

1.99

2.08

g/l

0.14

(4212803) Bone marrow aspirate examination

161

2.40

9.86

1.1

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

134

2.54

9.81

1.2

1.1

62.98

56.09

u/l

0.14

117

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

176

506

1.74

9.74

1.3

1.2

89.07

65.21

mg/l

0.19

120

358

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

171

488

1.76

9.70

1.7

1.4

0.20

0.25

nmol/l

0.90

124

350

(3041672) Baker's yeast Ab [Presence] in Serum

138

2.51

9.68

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

338

1144

1.48

9.65

1.9

—

(3016750) Collection duration of Urine

399

1395

1.43

9.65

2.6

2.1

504.36

496.81

min

0.78

303

1081

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2429

10570

1.16

9.60

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1904

11118

0.85

9.49

1.5

1.13

1.17

ratio

0.82

1145

6596

(3039744) RNA polymerase III Ab [Units/volume] in Serum

187

2.25

9.42

1.1

1.0

9.44

2.64

u/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

133

354

1.88

9.42

1.3

36.59

42.86

mg/l

0.85

112

302

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1911

11148

0.85

9.41

1.5

1.15

1.19

ratio

1.10

1161

6682

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1911

11148

0.85

9.41

1.5

0.94

0.95

ratio

0.27

1152

6627

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

102

2.75

9.35

1.1

1.0

8.24

8.71

0.48

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

103

2.72

9.20

1.1

1.0

20.23

21.57

1.25

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.61

9.06

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

131

353

1.86

8.96

1.5

1.6

—

(3013466) aPTT in Blood by Coagulation assay

153

2.36

8.96

1.1

1.2

36.47

37.24

0.28

127

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1882

10932

0.86

8.79

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

126

338

1.87

8.75

1.2

1.47

1.19

mmol/l

0.19

219

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

155

2.33

8.73

1.1

8.83

15.30

iu/ml

0.76

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

171

2.26

8.72

1.3

1.2

107.42

100.08

ug/l

0.17

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

215

2.10

8.59

1.4

1.2

51.59

44.83

mg/l

0.60

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

326

1124

1.45

8.55

2.1

170.88

81.23

ug/min

0.66

251

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2035

11723

0.87

8.50

1.5

61.45

62.46

ug/l

0.36

1684

9785

(3014891) Appearance of Pleural fluid

102

257

1.99

8.48

1.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

110

285

1.93

8.47

1.2

1.3

72.86

177.64

u/l

0.46

210

(3027974) Hepatitis B virus e Ag [Presence] in Serum

167

2.25

8.46

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.11

8.41

1.2

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.40

8.40

8.9

6.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.25

8.37

1.1

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

120

323

1.86

8.28

1.8

1.64

1.74

mg/l

0.30

101

270

(3041918) Cholesterol [Moles/volume] in Pleural fluid

148

426

1.74

8.24

1.2

1.47

1.73

mmol/l

1.91

259

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

9.52

8.24

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

189

2.15

8.21

1.0

3.09

0.78

u/ml

0.54

179

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.73

8.12

1.2

0.06

0.09

g/l

1.20

(3051387) C reactive protein [Mass/volume] in Capillary blood

1393

5880

1.19

8.10

4.2

2.9

27.06

26.85

mg/l

0.07

965

3985

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2692

11946

1.13

8.05

1.9

1.6

4.82

3.95

mg/l

2.97

2128

8467

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

331

1159

1.43

8.04

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

122

334

1.83

8.01

1.0

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

3.56

7.96

8.2

7.4

39.64

40.39

0.04

(4281824) Cell count and differential, peritoneal fluid

737

2924

1.26

7.82

1.2

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

4.61

7.73

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.71

7.70

1.0

1.1

0.06

0.08

u/ml

0.07

(3011325) HIV 1+2 Ab [Presence] in Serum

120

2.42

7.69

1.1

1.0

0.09

0.08

0.56

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

128

361

1.78

7.67

1.0

0.15

1.99

u/ml

0.85

162

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

107

286

1.87

7.58

1.0

1.1

2.07

0.71

u/ml

0.69

208

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

153

2.23

7.54

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.61

7.53

1.0

—

(44786800) Granulocytes/Leukocytes in Body fluid

228

1.98

7.44

1.3

24.84

25.64

0.07

178

(3007919) Fasciola sp Ab [Titer] in Serum

3.45

7.41

1.0

1.1

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

2.90

7.40

1.1

1.2

270.34

387.48

pmol/l

0.61

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.76

7.32

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

438

1636

1.34

7.30

1.4

5.65

5.55

mmol/l

0.92

410

1555

(3018291) Platelet Ab [Presence] in Serum

4.04

7.29

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

203

2.02

7.22

1.2

15.60

15.76

nmol/l

0.02

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

167

2.13

7.12

1.1

8.23

10.01

u/l

0.42

167

(3013945) Hepatitis B virus e Ab [Presence] in Serum

161

2.15

7.05

1.6

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.91

7.03

1.3

100.83

35.91

e6/l

0.75

(3022229) Phosphate [Moles/volume] in Urine

152

2.18

6.97

1.4

2.2

19.16

19.59

mmol/l

0.05

135

(3021691) Plasmodium malariae Ab [Titer] in Serum

5.01

6.94

2.5

2.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

195

633

1.54

6.92

1.1

1.2

7.83

7.56

u/ml

0.02

121

418

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

103

2.43

6.74

1.7

1.5

0.00

0.11

u/l

0.73

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.38

6.72

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.38

6.72

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.38

6.72

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.38

6.72

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.38

6.72

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.38

6.72

2.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.91

6.71

1.0

0.49

0.87

u/ml

0.37

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1170

4956

1.19

6.64

1.1

0.41

u/ml

0.01

415

1482

(3020618) Glucose [Moles/volume] in Synovial fluid

2.92

6.58

1.0

1.1

5.57

4.49

mmol/l

0.68

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1366

5867

1.17

6.56

1.1

4.56

4.02

u/ml

0.38

703

2980

(3013336) Amino acids [Identifier] in Serum or Plasma

2.81

6.52

2.3

2.5

—

(3049233) Organic acids panel - Urine

4.08

6.51

1.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

116

335

1.74

6.50

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1294

5539

1.17

6.49

1.1

5.29

5.17

u/ml

0.06

598

2535

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

212

1.94

6.47

1.1

87.02

96.60

titre

0.59

212

(3023436) Glucagon [Mass/volume] in Serum or Plasma

118

2.29

6.45

2.0

1.9

197.94

195.81

ng/l

0.07

104

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.43

6.33

1.2

1.1

329.89

437.62

u/l

0.29

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.94

6.25

1.1

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.40

6.21

11.2

8.9

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.73

6.21

1.1

1.91

0.93

u/field

0.60

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

219

1.90

6.20

1.0

1.1

0.39

0.59

u/ml

0.19

219

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

122

363

1.68

6.18

1.0

0.09

0.41

u/ml

1.14

166

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

152

479

1.59

6.17

2.1

1.8

2.28

2.85

ug/l

0.40

300

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

404

1538

1.32

6.01

1.2

9.23

9.52

mm/h

0.21

404

1538

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2509

11301

1.12

5.94

1.5

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

126

2.19

5.94

1.4

1.3

2382.00

620.73

u/l

0.58

113

(3027231) Wheat IgE Ab [Units/volume] in Serum

205

700

1.47

5.82

1.1

5.36

2.71

u/ml

0.35

174

618

(3009992) Blasts/cells in Bone marrow

9.30

5.74

1.9

1.0

18.00

31.00

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.96

5.62

1.0

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

4.48

5.59

1.0

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1019

4335

1.18

5.58

1.4

1.3

7.17

7.01

mmol/l

0.95

910

3848

(44806420) Estimation of glomerular filtration rate

853

3574

1.20

5.56

2.5

2.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

105

310

1.70

5.52

1.3

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

10.01

5.51

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

108

322

1.68

5.48

3.0

69.21

77.90

pmol/l

0.27

285

(3021374) Sirolimus [Mass/volume] in Blood

5.72

5.33

11.2

5.4

7.09

6.99

ug/l

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

3.71

5.32

1.1

26.07

28.89

umol/24h

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

119

2.15

5.32

10.4

7.7

103.37

106.27

g/l

0.72

119

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

11.02

5.28

3.9

2.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1057

6150

0.86

5.24

1.3

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

151

1.99

5.18

1.9

1.6

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

131

2.06

5.13

4.4

3.6

0.00

estimate

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3890

21009

0.92

5.08

1.6

1001.90

1019.41

mu/l

0.42

3234

17916

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.96

5.05

1.0

0.03

0.13

u/ml

0.53

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

129

412

1.57

5.05

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

136

440

1.55

5.03

6.9

6.4

10.43

10.76

0.84

136

440

(3010937) Rubella virus Ab [Presence] in Serum

207

1.82

4.98

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

110

340

1.62

4.93

1.0

1.1

2.64

0.45

u/ml

0.52

161

(3014599) Egg white IgE Ab [Units/volume] in Serum

555

2258

1.23

4.92

1.1

2.88

4.19

u/ml

0.29

155

579

(3017461) Flecainide [Moles/volume] in Serum or Plasma

127

2.05

4.88

1.4

1.8

0.68

umol/l

0.02

104

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.64

4.81

1.1

1.2

232.40

286.92

u/ml

0.85

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

123

394

1.56

4.78

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

225

1.76

4.76

1.5

1.2

378.14

257.74

mg/24h

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

150

1.94

4.69

1.3

1.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

274

1.66

4.54

1.7

1.6

—

(3022475) Manganese [Moles/volume] in Blood

145

1.93

4.52

1.1

1.3

0.17

0.15

umol/l

1.82

145

(3016031) Almond IgE Ab [Units/volume] in Serum

244

1.70

4.51

1.1

1.0

0.72

0.92

u/ml

0.30

153

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

164

1.86

4.43

3.6

5.6

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.09

4.40

1.3

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

191

1.78

4.33

1.5

302.25

311.19

umol/24h

0.14

191

(3017400) Magnesium [Moles/volume] in Urine

2.66

4.26

1.3

1.1

2.01

3.13

mmol/l

1.58

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

390

1553

1.26

4.26

1.7

1.9

1.58

3.12

u/ml

2.36

476

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.42

4.14

1.4

160.39

133.83

nmol/l

0.33

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

209

1.73

4.13

1.1

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10809

52065

1.05

4.13

3.0

3.1

0.74

0.77

ug/l

1.18

6957

31828

(3020874) Milk IgE Ab [Units/volume] in Serum

563

2347

1.20

4.02

1.1

1.18

2.98

u/ml

1.41

199

750

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.24

4.00

1.0

0.07

0.33

u/ml

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

7.15

3.99

1.1

1.0

—

(3006462) Nitrate [Presence] in Urine

318

1248

1.28

3.95

3.1

2.7

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.19

3.92

1.1

1.0

0.12

0.05

u/ml

0.46

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

292

1135

1.29

3.91

1.0

1.04

0.56

u/ml

0.60

285

1117

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

297

1158

1.29

3.89

1.0

10.33

10.73

u/ml

0.11

182

770

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

3.58

3.85

1.3

7.93

21.28

u/ml

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

100

323

1.55

3.84

1.1

1.0

0.71

6.17

u/ml

0.54

168

(3001729) Color of Synovial fluid

173

1.77

3.81

1.5

1.7

—

(3018001) Oat IgE Ab [Units/volume] in Serum

228

1.65

3.69

1.1

1.0

0.24

0.79

u/ml

0.62

131

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.03

3.67

2.1

240.17

242.47

ug/l

0.02

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.03

3.67

1.2

4611.00

3153.43

ng/l

0.45

(3035611) Eosinophils/Leukocytes in Synovial fluid

146

1.82

3.65

1.5

1.8

1.14

0.49

0.81

113

(4211845) Urine protein measurement

347

1392

1.25

3.63

3.0

2.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

499

2079

1.20

3.63

1.0

1.23

0.64

u/ml

0.50

138

498

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.62

3.56

3.4

2.0

2.43

2.92

mu/l

0.12

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

5.01

3.50

1.0

1.7

304.91

294.82

nmol/l

0.07

(40762887) Creatinine [Moles/volume] in Blood

163

1.75

3.50

1.6

1.3

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.37

3.47

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.37

3.47

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.91

3.47

1.1

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

139

493

1.41

3.43

1.2

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

249

1.59

3.40

1.4

72.50

71.91

0.06

214

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.62

3.40

1.8

1.2

3.25

7.83

mg/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

219

1.62

3.34

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.40

3.18

1.1

1.0

4.00

2.35

1.30

(3012989) Citrate [Moles/time] in 24 hour Urine

2.25

3.13

1.6

1.5

1.81

2.23

mmol/24h

0.86

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.00

3.12

1.1

246.48

303.71

nmol/l

0.49

(4146454) Self-monitoring of blood glucose

638

2763

1.16

3.01

2.9

2.8

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.15

2.95

1.1

0.02

0.04

g/l

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

247

1.54

2.93

1.0

1.1

4.29

8.52

u/ml

1.86

137

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.89

1.4

1.0

1.27

1.50

0.14

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

508

2967

0.86

2.86

1.6

1.5

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.26

2.83

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

114

1.80

2.82

1.0

—

(3025130) Human papilloma virus identified in Specimen

1217

5515

1.11

2.80

1.8

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.16

2.78

1.5

1.7

98.43

122.69

ug/l

0.35

(3018738) Hemoglobin F/Hemoglobin.total in Blood

187

1.61

2.77

5.1

2.4

11.95

12.19

0.02

(3028468) Fragments [Presence] in Blood by Light microscopy

4.51

2.74

2.7

2.2

—

(3026470) Cobalt [Mass/volume] in Blood

336

1392

1.21

2.71

2.2

2.3

4.53

3.47

ug/l

0.82

307

1296

(3020650) Glucose [Presence] in Urine

267

1082

1.24

2.67

1.7

1.5

0.07

0.04

estimate

0.48

267

1082

(3007456) Orange IgE Ab [Units/volume] in Serum

2.07

2.63

1.0

0.09

0.27

u/ml

0.44

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.38

2.62

1.0

1.1

0.09

0.27

u/ml

0.82

(3041184) Isoniazid [Presence] in Urine

2.96

2.61

3.3

2.3

—

(3045177) Copper [Moles/volume] in Urine

2.44

2.60

1.2

1.0

0.82

0.28

umol/l

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.09

2.59

1.0

2.43

1.01

u/ml

0.26

(3025577) Chromium [Mass/volume] in Blood

325

1351

1.21

2.55

2.2

2.3

2.59

2.30

ug/l

0.44

272

1139

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

4.10

2.55

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

120

441

1.36

2.51

1.0

78.05

81.60

ug/l

0.38

350

(3007700) Barley IgE Ab [Units/volume] in Serum

165

1.61

2.50

1.1

1.0

0.41

8.90

u/ml

0.51

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

4.45

2.46

1.1

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.84

2.44

1.0

0.12

0.18

u/ml

0.20

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.01

2.39

1.0

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

187

1.55

2.38

1.1

1.0

0.47

11.01

u/ml

0.51

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.76

2.38

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1239

5673

1.10

2.37

1.5

1.3

3.61

ug/l

0.00

1107

5175

(3030703) Everolimus [Mass/volume] in Blood

6.01

2.34

24.8

8.8

4.35

5.06

ug/l

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.36

2.33

1.1

100.67

88.44

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

447

1931

1.16

2.29

1.1

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.02

2.23

1.9

1.2

410.09

415.23

mg/24h

0.03

(3006969) Lambda light chains [Mass/volume] in Urine

1.97

2.19

1.0

1.1

0.14

0.02

g/l

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

3.13

2.19

4.9

1.7

—

(3032641) Amino acids panel - Urine

2.60

2.14

1.1

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

129

1.63

2.13

1.1

0.27

1.49

u/ml

1.23

129

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

141

1.60

2.11

1.3

1.4

1.55

1.78

mg/l

0.68

116

(3019529) Immunofixation for Cerebral spinal fluid

5.01

2.10

1.7

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.11

2.07

1.0

0.51

0.61

u/ml

0.08

(3027874) Urate [Moles/volume] in Urine

1.74

2.05

1.1

1.56

8.43

mmol/l

0.53

(3032868) Hemoglobin electrophoresis panel in Blood

291

1.39

2.01

1.5

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.10

1.94

1.4

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

3.00

1.93

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

179

724

1.24

1.93

1.1

33.30

29.06

iu/ml

0.43

179

724

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

162

1.51

1.87

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

234

1.41

1.80

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

372

1.32

1.77

2.4

2.6

4.32

3.51

ug/l

0.47

132

(3046914) Granular casts [#/area] in Urine by Computer assisted method

2.15

1.72

1.3

1.4

0.75

0.56

u/field

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.94

1.71

2.2

2.1

23.13

29.56

1.02

(3050129) First trimester maternal screen panel - Serum or Plasma

2604

13681

0.95

1.65

1.5

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

120

478

1.26

1.55

1.0

10.37

8.90

u/ml

0.15

120

478

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.63

1.44

1.2

33.20

31.72

mg/24h

0.12

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

3.58

1.44

2.6

3.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

266

1153

1.16

1.44

3.0

3.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.70

1.43

1.0

1.1

20.43

36.23

umol/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

320

1.30

1.41

2.8

2.2

0.54

0.61

u/field

0.27

320

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

212

1.37

1.40

1.4

7.54

5.86

u/ml

0.12

174

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.57

1.38

1.3

1.05

1.12

u/field

0.24

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

646

2959

1.09

1.38

1.6

7.92

7.61

mmol/l

3.02

622

2841

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.67

1.37

1.0

1.1

9.63

20.73

umol/l

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

2.50

1.32

1.9

1.3

—

(3007147) Virus identified in Stool by Electron microscopy

2.73

1.30

1.0

—

(40758358) Immune stain study

1.55

1.28

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

280

1589

0.88

1.25

1.6

1.4

0.52

0.51

e9/l

0.18

280

1589

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

120

1.46

1.22

1.0

0.56

0.26

u/ml

0.41

(3036312) Salmon IgE Ab [Units/volume] in Serum

192

1.36

1.21

1.1

0.61

2.74

u/ml

1.56

132

(3009883) Potato IgE Ab [Units/volume] in Serum

1.78

1.18

1.0

0.28

0.45

u/ml

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.09

1.11

1.2

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

2.34

1.11

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.45

1.07

1.2

0.68

0.32

umol/l

—

(46235168) Fasting glucose [Moles/volume] in Blood

408

1.22

1.03

3.6

1.3

7.44

7.08

mmol/l

0.34

113

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

126

1.39

0.99

1.0

0.58

0.23

u/ml

0.48

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.59

0.97

1.0

—

0.98

—

(3003577) Lead [Moles/volume] in Blood

281

1.25

0.95

1.3

1.5

0.18

0.33

umol/l

0.91

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.31

0.95

1.0

1.2

29.65

38.85

nmol/24h

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.15

0.89

1.2

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.63

0.87

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

443

0.82

0.85

4.9

5.8

9.62

8.31

mmol/l

1.02

443

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.28

0.78

1.0

1.2

42.70

31.14

ug/l

—

(3043614) Bacteria identified in Aspirate by Culture

2.28

0.78

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

142

0.71

0.76

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

166

738

1.13

0.75

1.9

2.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.84

0.74

1.0

1.1

0.96

0.87

u/ml

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.59

0.70

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.39

0.69

1.0

1.1

11.95

12.48

mg/l

0.03

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.63

0.64

5.2

5.5

0.12

0.24

mmol/l

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.35

0.63

1.0

7179.89

10019.35

ng/l

—

(3003157) Bacteria [#/volume] in Mother's milk

1.39

0.62

6.0

6.8

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.60

0.62

1.0

0.03

0.19

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

146

814

0.90

0.60

1.3

1.2

61.17

68.48

ug/l

1.03

146

814

(4038314) Semen analysis, post vasectomy

304

1.17

0.58

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

1.67

0.57

1.0

1.3

292.83

81.89

nmol/l

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.48

0.55

1.5

1.3

69.08

75.67

0.13

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.72

0.50

1.0

164.46

163.64

g/l

0.05

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

1.34

0.50

1.0

9.09

10.01

u/ml

0.06

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

213

1.18

0.46

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1518

7803

0.97

0.45

1.5

59.66

60.50

ug/l

0.31

1518

7803

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1007

4882

1.03

0.45

3.2

2.3

13.13

0.03

996

4821

(3013762) Body weight Measured

1.28

0.44

1.1

1.2

—

(40760512) CD34 cells/cells in Bone marrow

1.56

0.42

1.6

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.47

0.42

1.0

1.1

3030.60

3483.94

titre

—

(40765089) Chromosome analysis panel - Blood by G-banded

286

1350

1.06

0.42

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3490

17755

0.98

0.41

1.7

1.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

336

1.12

0.38

1.4

1.2

20.94

20.57

mmol/l

0.32

278

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.43

0.38

1.0

1.1

1508.00

2218.57

titre

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.37

0.35

1.0

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

117

1.20

0.34

1.0

0.47

0.79

u/ml

0.22

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.24

0.33

1.0

1.16

3.66

u/ml

1.00

(3014178) Parietal cell Ab [Units/volume] in Serum

1.35

0.32

1.3

1.0

45.86

55.04

u/ml

—

(3006598) pH of Arterial cord blood

233

0.88

0.30

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

233

0.88

0.30

1.0

6.98

7.24

kpa

0.52

205

(3004959) Base excess in Arterial cord blood by calculation

230

0.89

0.26

1.0

-1.09

-1.76

mmol/l

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.39

0.24

1.0

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

1.25

0.24

1.0

0.15

3.11

u/ml

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

0.22

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

226

0.91

0.20

1.0

3.70

3.78

kpa

0.05

195

(3022670) pH of Venous cord blood

0.86

0.17

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

231

1.06

0.12

1.0

9.52

8.43

mu/l

0.46

184

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.12

0.11

1.4

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

2000

10085

0.99

0.11

1.6

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.16

0.09

1.0

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

399

1.03

0.07

1.2

1.4

5.80

5.76

mmol/l

0.10

399

(40761995) Spermatozoa Progressive [#/volume] in Semen

200

986

1.02

0.06

3.1

3.3

40.32

45.78

2.86

200

986

(4133840) Spirometry

180

887

1.02

0.06

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

1.09

0.06

1.1

1.4

—

(40768800) Prostate Pathology biopsy report

1040

5236

0.99

0.05

1.2

—

(3034614) HLA Ag [Interpretation]

1.08

0.05

1.4

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

518

2608

0.99

0.03

1.4

1.3

182.52

189.00

pmol/l

0.12

518

2608

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

199

987

1.01

0.03

6.3

6.6

9.02

8.72

0.27

199

987

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

181

0.97

0.03

1.1

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

465

2329

1.00

0.00

1.4

1.5

31.17

34.86

nmol/l

1.66

416

2167

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

327

1.00

0.00

1.0

1.1

1.13

1.18

mom

0.24

327

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.91

-0.00

1.2

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_GENERAL_SYMPTOMS_SIGNS – General symptoms and signs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

General symptoms and signs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for General symptoms and signs (R18_GENERAL_SYMPTOMS_SIGNS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints